Page last updated: 2024-11-04

edelfosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

edelfosine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

(R)-edelfosine : A 1-octadecyl-2-methylglycero-3-phosphocholine that is the (R)-enantiomer of edelfosine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID1392
CHEMBL ID28509
CHEBI ID78652
SCHEMBL ID52069
MeSH IDM0087341
PubMed CID6918215
CHEMBL ID107514
CHEBI ID78653
SCHEMBL ID436257
MeSH IDM0087341

Synonyms (138)

Synonym
ro-14-5243
(+/-)-et-18-ome
(+/-)-et-18-och3
nsc343649
nsc-343649
ALP ,
choline, 1-octadecyl-2-methoxy-3-phosphoryl-
nsc324368 ,
phosphorylcholine, 1-octadecyl-2-methyl- (alp)
edelfosine
nsc-324368
1-octadecyl-2-methylphosphorylcholine
3,9-trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n-trimethyl-, hydroxide, inner salt, 4-oxide
65492-82-2
et-18-o me
2-[hydroxy-(2-methoxy-3-octadecoxy-propoxy)phosphoryl]oxyethyl-trimethyl-ammonium
70641-51-9
3,5,9-trioxa-4-phosphaheptacosan-1-aminium,4-hydroxy-n,n,n-trimethyl-, hydroxide,inner salt,4-oxide
1-octadecyl-2-methylglycero-3-phosphorylcholine
1-o-octadecyl-2-o-methyl-rac-glyceryl-3-phosphorylcholine
1-o-octadecyl-2-o-methyl-rac-glycero-3-phosphocholine
et 18-och3
racemic 1-o-octadecyl-2-o-methylglycero-3-phosphocholine
et-18-ome
rac-1-octadecyl-2-methoxyglycero-3-phosphocholine
3,5,9-trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n-trimethyl-, inner salt, 4-oxide (9ci)
choline hydroxide, (+-)-2-methoxy-3-(octadecyloxy)propyl hydrogen phosphate, inner salt
3,5,9-trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n-trimethyl-, inner salt, 4-oxide, (+/-)-
ethanaminium, 2-[[hydroxy[2-methoxy-3-(octadecyloxy)propoxy]phosphinyl]oxy]-n,n,n-trimethyl-, inner salt
cmc_9491
ro 14-5243
edelfosinum [inn-latin]
3,5,9-trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n-trimethyl-, hydroxide, inner salt, 4-oxide, (+-)-
edelfosine [inn]
brn 4358577
edelfosina [inn-spanish]
1-octadecyl-2-methylglycero-3-phosphocholine
nsc 324368
O-0318
chebi:78652 ,
CHEMBL28509 ,
2-methoxy-3-(octadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate
(2-methoxy-3-octadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
phosphoric acid 2-dimethylamino-ethyl ester 2-methoxy-3-octadecyloxy-propyl ester; ammonium
{2-[hydroxy-(2-methoxy-3-octadecyloxy-propoxy)-phosphoryloxy]-ethyl}-trimethyl-ammonium
phosphoric acid 2-trimethylamino-ethyl ester 2-methoxy-3-octadecyloxy-propyl ester
bdbm50011796
{2-[hydroxy-(2-methoxy-3-octadecyloxy-propoxy)-phosphoryloxy]-ethyl}-trimethyl-ammonium(et-18-ome)
1-octadecyl-2-methoxy-rac-glycero-3-phosphocholine(et-18-ome)
1y6sna8l5s ,
nsc 343649
edelfosina
edelfosinum
unii-1y6sna8l5s
GA40290000 ,
choline hydroxide, 2-methoxy-3-(octadecyloxy)propyl hydrogen phosphate, inner salt
niosh/ga4029000
rac-1-octadecyl-2-methoxy-glycerophosphocholine
tox21_111225
dtxcid401300168
dtxsid9045766 ,
cas-70641-51-9
3,5,9-trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n-trimethyl-, inner salt, 4-oxide
195154-26-8
choline hydroxide, (+/-)-2-methoxy-3-(octadecyloxy)propyl hydrogen phosphate, inner salt
SCHEMBL52069
2-methoxy-3-(octadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
edelfosine, >=95% (hplc)
mfcd00135190
FT-0773005
Q3579094
GLXC-25652
(+)-(r)-et-18-och3
(+)-(r)-edelfosine
(+)-(r)-et-18-ome
EU-0100430
et-18-och3
NCGC00093851-04
NCGC00093851-02
c27h58no6p
1-octadecyl-2-methyl-sn-glycero-3-phosphocholine
NCGC00093851-03
NCGC00093851-01
NCGC00093851-05
3,5,9-trioxa-4-phosphaheptacosan-1-aminium
E 1779
HMS1989G03
NCGC00093851-06
chebi:78653 ,
CHEMBL107514
BML3-F02
HMS1791G03
HMS1361G03
[(2r)-2-methoxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
HMS3261E22
CCG-204522
cas_77286-66-9
bdbm86730
1-o-octadecyl-2-o-methyl-sn-glycero-3-phosphorylcholine
LP00430
SCHEMBL436257
(2r)-2-methoxy-3-(octadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
(r)-edelfosine
pc(o-18:0/o-1:0)
NCGC00261115-01
tox21_500430
(7r)-4-hydroxy-7-methoxy-n,n,n-trimethyl-3,5,9-trioxa-4-phosphaheptacosan-1-aminium-4-oxide
1-o-octadecyl-2-o-methyl-sn-glyceryl-3-phosphorylcholine
MHFRGQHAERHWKZ-HHHXNRCGSA-N
2-o-methyl paf c-18
edelfosine; 1-octadecyl-2-o-methyl-glycero-3-phosphocholine
HB0278
AKOS024457387
HMS3402G03
77286-66-9
HMS3648P18
3,5,9-trioxa-4-phosphaheptacosan-1-aminium,4-hydroxy-7-methoxy-n,n,n-trimethyl-,inner salt,4-oxide
tlc-ell-12
edelfosine, (r)-
LZ198HY9OE ,
3,5,9-trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n-trimethyl-, inner salt, 4-oxide, (7r)-
1-stearyl-2-methyl-sn-glycero-3-phosphocholine
3,5,9-trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n-trimethyl-, inner salt, 4-oxide, (r)-
unii-lz198hy9oe
mfcd00063527
edelfosine, 1-o-octadecyl-2-o-methyl-sn-glycero-3-phosphocholine, chloroform
edelfosine, 1-o-octadecyl-2-o-methyl-sn-glycero-3-phosphocholine, powder
DTXSID20922896
Q27147892
et-18-och - cas 70641-51-9
3,5,9-trioxa-4-phosphaheptacosan-1-aminium,4-hydroxy-7-methoxy-n,n,n-trimethyl-, inner salt, 4-oxide, (7r)-
SDCCGSBI-0050415.P002
NCGC00093851-11
edelfosine;2-o-methyl-paf-c-18
(r)-2-methoxy-3-(octadecyloxy)propyl (2-(trimethylammonio)ethyl) phosphate
3,5,9-trioxa-4-phosphaheptacosan-1-aminium,4-hydroxy-7-methoxy-n,n,n-trimethyl-,inner salt,4-oxide,(7r)-
HY-108610
(r)-2-methoxy-3-(octadecyloxy)propyl(2-(trimethylammonio)ethyl)phosphate

Research Excerpts

Overview

Edelfosine (ET) is a potent antitumor agent but causes severe side effects that have limited its use in clinical practice. It is an anticancer drug with an asymmetric structure because, being a derivative of glycerol, it possesses two hydrophobic substituents of very different lengths.

ExcerptReferenceRelevance
"Edelfosine (ET) is a potent antitumor agent but causes severe side effects that have limited its use in clinical practice. "( In vivo biodistribution of edelfosine-loaded lipid nanoparticles radiolabeled with Technetium-99 m: Comparison of administration routes in mice.
Blanco-Prieto, MJ; Bouziotis, P; El Moukhtari, SH; Lasa-Saracíbar, B; Loudos, G; Tsotakos, T; Xanthopoulos, S, 2022
)
2.46
"Edelfosine is an FDA-approved investigational, anti-neoplastic drug."( Edelfosine reactivates latent HIV-1 reservoirs in myeloid cells through activation of NF-κB and AP1 pathway.
Gaur, R; Muhammadi, MK; Rai, M; Rawat, K, 2022
)
2.89
"Edelfosine is an anticancer drug with an asymmetric structure because, being a derivative of glycerol, it possesses two hydrophobic substituents of very different lengths. "( Anticancer Agent Edelfosine Exhibits a High Affinity for Cholesterol and Disorganizes Liquid-Ordered Membrane Structures.
Ausili, A; Corbalán-García, S; de Godos, AM; Gómez Fernández, JC; Gómez-Murcia, V; Martínez-Valera, P; Teruel, JA; Torrecillas, A, 2018
)
2.26
"Edelfosine is a synthetic ether lipid analogue of platelet activating factor with high antitumor activity."( In vitro intestinal co-culture cell model to evaluate intestinal absorption of edelfosine lipid nanoparticles.
Blanco-Prieto, MJ; Guada, M; Lasa-Saracíbar, B; Sebastián, V, 2014
)
1.35
"Edelfosine is a synthetic alkyl-lysophospholipid that possesses significant antitumor activity in several human tumor models. "( Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity.
Burnstein, KL; Mu, Z; Philip, S; Pollack, A; Shareef, MM; Stoyanova, R; Udayakumar, TS, 2016
)
3.32
"Edelfosine is a synthetic antitumor lipid of high selectivity. "( Searching for the role of membrane sphingolipids in selectivity of antitumor ether lipid-edelfosine.
Dynarowicz-Łatka, P; Hac-Wydro, K, 2010
)
2.03
"Edelfosine is an inhibitor of SK3 channel mediated cell migration. "( New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis.
Bougnoux, P; Chantome, A; Corbel, B; Couthon-Gourvès, H; Girault, A; Haelters, JP; Jaffrès, PA; Joulin, V; Marionneau-Lambot, S; Oullier, T; Pinault, M; Potier-Cartereau, M; Simon, G; Vandier, C, 2011
)
1.81
"Edelfosine is a synthetic alkyl ether phospholipid that represents a promising class of antitumor agents. "( Quantitative determination of the antitumor alkyl ether phospholipid edelfosine by reversed-phase liquid chromatography-electrospray mass spectrometry: application to cell uptake studies and characterization of drug delivery systems.
Blanco-Príeto, MJ; Campanero, MA; Mollinedo, F, 2004
)
2
"Edelfosine is a prototypical member of the alkylphosphocholine class of antitumor drugs. "( Cytotoxicity of an anti-cancer lysophospholipid through selective modification of lipid raft composition.
Cacharro, LM; Gajate, C; McMaster, CR; Mollinedo, F; Zaremberg, V, 2005
)
1.77
"Edelfosine is a surface-active soluble amphiphile, with critical micellar concentrations at 3.5 microM and 19 microM in water."( Surface-active properties of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (edelfosine).
Alonso, A; Busto, JV; Goñi, FM; Mollinedo, F; Sot, J, 2007
)
1.27
"Edelfosine is an alkyl-lysophospholipid that acts as an anticancer agent in vivo. "( The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivo.
Ades, EW; Bouck, N; Liu, J; Vogler, WR; Volpert, O, 1998
)
2.07

Effects

Edelfosine has been shown to accumulate in plasma membrane lipid rafts, ER and mitochondria in different tumor cells. It has been proposed for the treatment of autoimmune diseases like multiple sclerosis (MS)

ExcerptReferenceRelevance
"Edelfosine has been shown to accumulate in plasma membrane lipid rafts, ER and mitochondria in different tumor cells in a cell type-dependent way."( Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate, C; Mollinedo, F, 2014
)
1.34
"Edelfosine has been proposed for the treatment of autoimmune diseases like multiple sclerosis (MS)."( The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response.
Abramowski, P; Martin, R; Otto, B, 2014
)
1.38
"Edelfosine has been found to increase the fluidity of model membranes, however, at a lower concentration (up to 5% of edelfosine in model system) this compound affects only the condensation of tumor cell model membrane, while practically does not modify the organization of normal model system."( Effect of edelfosine on tumor and normal cells model membranes--a comparative study.
Dynarowicz-Łatka, P; Hac-Wydro, K, 2010
)
1.48

Actions

ExcerptReferenceRelevance
"Edelfosine did not inhibit ¹²⁵I-Apamin binding to this SK(Ca) channel; rather, it reduced the calcium sensitivity of SK3/K(Ca)2.3 channel and dramatically decreased intracellular Ca²(+) concentration, probably by insertion in the plasma membrane, as suggested by proteinase K experiments."( The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine.
Besson, P; Bougnoux, P; Chantome, A; Girault, A; Joulin, V; Jourdan, ML; LeGuennec, JY; Potier, M; Roger, S; Vandier, C, 2011
)
1.33

Treatment

Edelfosine oral treatment also showed in vivo schistosomicidal activity and decreased significantly the egg burden in the liver. Treatment recruited Hsp90, c-Jun N-terminal kinase (JNK), but not the JNK regulators apoptosis signal-regulating kinase 1 (ASK1) and Daxx.

ExcerptReferenceRelevance
"Edelfosine treatment also induced a redistribution of lipid rafts from the plasma membrane to mitochondria, suggesting a raft-mediated link between plasma membrane and mitochondria."( Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate, C; Mollinedo, F, 2014
)
1.34
"Edelfosine oral treatment also showed in vivo schistosomicidal activity and decreased significantly the egg burden in the liver, a key event in schistosomiasis."( In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosine.
Dakir, EL; Dakir, el H; López-Abán, J; Mollinedo, F; Muro, A; Varela-M, RE; Yepes, E, 2014
)
1.35
"Edelfosine oral treatment in rats, at doses 8-fold higher than those displaying anti-inflammatory action, lacked toxicity."( Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis.
Collía, F; del Canto-Jañez, E; Gajate, C; Iglesias, A; Justies, N; Modolell, M; Mollinedo, F; Morales, AI; Rivas, JV, 2009
)
1.35
"Edelfosine treatment recruited Hsp90, c-Jun N-terminal kinase (JNK) and apoptotic molecules in lipid rafts, but not the JNK regulators apoptosis signal-regulating kinase 1 (ASK1) and Daxx, or the survival signaling molecules extracellular signal-regulated kinase (ERK) and Akt."( Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
Gajate, C; González-Camacho, F; Mollinedo, F; Nieto-Miguel, T, 2008
)
1.29
"Edelfosine treatment led to the generation of the p20 caspase-8 cleavage fragment of BAP31, directing proapoptotic signals between the ER and the mitochondria."( Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells.
Fonteriz, RI; Gajate, C; López-Hernández, S; Mollinedo, F; Nieto-Miguel, T; Vay, L, 2007
)
1.3
"Oral treatment of edelfosine diminished inflammation in two murine animal models."( Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis.
Collía, F; del Canto-Jañez, E; Gajate, C; Iglesias, A; Justies, N; Modolell, M; Mollinedo, F; Morales, AI; Rivas, JV, 2009
)
0.96

Toxicity

ExcerptReferenceRelevance
" CP-46,665 was the most toxic compound, but did not reveal significant differences between nonneoplastic bone marrow and leukemic cells when added in concentrations greater than 1 microgram/ml."( Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Berdel, WE; Eibl, H; Fink, U; Fromm, M; Jehn, U; Rastetter, J; Reichert, A; Schick, HD; Ulm, K; Unger, C, 1987
)
0.27
"5 mg/kg (no observed adverse effects) and 62."( Toxicity and disposition of TLC ELL-12 (liposomal antitumor ether lipid) in Sprague-Dawley rats.
Bhamra, R; Bolcsak, LE; Cavanaugh, C; Roberts, P; Stevens, R; Swenson, CE, 2003
)
0.32
" LN are made of lipids recognized as safe by the Food and Drug Administration (FDA) and, therefore, these systems are generally considered as nontoxic vehicles."( Lipid nanoparticles protect from edelfosine toxicity in vivo.
Aizpún, I; Aznar, MÁ; Blanco-Prieto, MJ; Gil, AG; Lana, H; Lasa-Saracíbar, B, 2014
)
0.68

Pharmacokinetics

ExcerptReferenceRelevance
" Besides, no statistical differences were observed between the pharmacokinetic parameters of BALB/c and SCID mice."( Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice.
Blanco-Prieto, MJ; Campanero, MA; de la Iglesia-Vicente, J; Estella-Hermoso de Mendoza, A; Gajate, C; Mollinedo, F, 2009
)
0.65
" Their anticancer activity was tested in pediatric cancer cell lines and pharmacokinetic studies were performed in mice."( Squalenoyl-gemcitabine/edelfosine nanoassemblies: Anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice.
Blanco-Prieto, MJ; Couvreur, P; Mura, S; Rodríguez-Nogales, C, 2020
)
0.87

Compound-Compound Interactions

ExcerptReferenceRelevance
"High-dose chemotherapy combined with autologous stem cell support has improved response rates in high-risk and metastatic breast cancer, but has failed to improve long-term survival."( Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients.
Anderson, GS; Miyagi, K; Sampson, RW; Sieber, F, 2002
)
0.54

Bioavailability

This provided an increase in relative oral bioavailability of 1500% after a single oral administration of drug-loaded LNs. Encapsulation of edelfosine (ET) in lipid nanoparticles (LNs) improves its oral bio availability and decreases its toxicity.

ExcerptReferenceRelevance
" This indicates that the bioavailability of He-PC and ET18-OCH3 is not controlled by differences in the uptake of the two drugs, but by differences in their metabolism."( Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment.
Eibl, H; Kötting, J; Marschner, N; Unger, C, 1992
)
0.28
"The present study investigates and compares the dose-dependent pharmacokinetics and oral bioavailability of edelfosine in healthy, immunodeficient, and tumor-bearing immunosuppressed mouse animal models, as well as edelfosine uptake and apoptotic activity in the Z-138 mantle cell lymphoma (MCL) cell line."( Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice.
Blanco-Prieto, MJ; Campanero, MA; de la Iglesia-Vicente, J; Estella-Hermoso de Mendoza, A; Gajate, C; Mollinedo, F, 2009
)
0.86
" Bioavailability for a single oral dose of edelfosine was <10%, but a multiple-dose oral administration increased this value up to 64%."( Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice.
Blanco-Prieto, MJ; Campanero, MA; de la Iglesia-Vicente, J; Estella-Hermoso de Mendoza, A; Gajate, C; Mollinedo, F, 2009
)
0.91
"This provided an increase in relative oral bioavailability of 1500% after a single oral administration of drug-loaded LNs, maintaining edelfosine plasma levels over 7 days in contrast to a single oral administration of edelfosine solution, which presented a relative oral bioavailability of 10%."( Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles.
Blanco-Prieto, MJ; Campanero, MA; de la Iglesia-Vicente, J; Estella-Hermoso de Mendoza, A; Lana, H; Mollinedo, F; Villa-Pulgarin, JA, 2012
)
0.82
" Encapsulation of edelfosine (ET) in lipid nanoparticles (LNs) improves its oral bioavailability and decreases its toxicity."( Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines.
Blanco-Príeto, MJ; Estella-Hermoso de Mendoza, A; Lasa-Saracíbar, B; Mollinedo, F; Odero, MD, 2013
)
2.17
" The prolonged blood circulation potential of micellar formulations might improve the therapeutic potential of drug by increasing its bioavailability in the serum."( Transferrin-conjugated polymeric nanomedicine to enhance the anticancer efficacy of edelfosine in acute myeloid leukemia.
Sun, Y; Sun, ZL, 2016
)
0.66
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" All the mice given cells not treated with ALP succumbed to leukemia, whereas there was a dose-response increase in survival in those given ALP treated cells."( Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Berdel, WE; Glasser, L; Okamoto, S; Olson, AC; Vogler, WR, 1990
)
0.28
" Treatment of established tumors (experiment B) with 6 and 60 mg/kg ET-18-OCH3 daily for 3 weeks effected a stagnation in tumor growth for the higher dosage only with 90% tumor inhibition in comparison to untreated controls; at the same time, however, clear toxic effects were seen, thus indicating a narrow therapeutic index of ET-18-OCH3 in single-drug therapy."( Influence of the alkyllysophospholipid ET-18-OCH3 on methylnitrosourea-induced rat mammary carcinomas.
Berger, MR; Munder, PG; Schmähl, D; Westphal, O, 1984
)
0.27
" In B16F1 and B16F10 cultures the dose-response curve was not affected by the number of cells/well, while in B16BL6 no more than 20% of the cells were killed at all cell densities measured."( Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.
Magistrelli, A; Salmona, M; Tacconi, MT; Trulla, LL, 1993
)
0.29
" Dose-response curves after drug exposure for 4 and 24 hours reached plateaus at 75 and 25 microg/mL, respectively."( Response of human multiple myeloma-derived cell lines to alkyl-lysophospholipid.
Cook, P; Dalton, WS; Fiederlein, RL; Glasser, L; Powis, G; Vogler, WR, 1996
)
0.29
" In these cells at low dosage (from 1 to 6 microg/ml of medium) ET-18-OCH(3) stimulates maturation and protective responses, whereas at increasing dosages (from 8 to 20 microg/ml) it shows cytotoxic effects."( ET-18-OCH(3)-induced cytotoxicity and DNA damage in rat astrocytes.
Cardile, V; Palumbo, M; Renis, M; Russo, A, 2000
)
0.31
"Paediatric solid tumours exhibit steep dose-response curves to alkylating agents and are therefore considered candidates for high-dose chemotherapy and autologous stem cell support."( Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts.
Anderson, GS; Miyagi, K; Sampson, R; Sieber, F; Tsujino, I, 2003
)
0.52
" Daily dosing at 12."( Toxicity and disposition of TLC ELL-12 (liposomal antitumor ether lipid) in Sprague-Dawley rats.
Bhamra, R; Bolcsak, LE; Cavanaugh, C; Roberts, P; Stevens, R; Swenson, CE, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
glycerophosphocholineThe glycerol phosphate ester of a phosphocholine. A nutrient with many different roles in human health.
1-octadecyl-2-methylglycero-3-phosphocholineA glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (38)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency33.49150.000323.4451159.6830AID743065; AID743067
Chain A, Ferritin light chainEquus caballus (horse)Potency19.95265.623417.292931.6228AID2323
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
thioredoxin reductaseRattus norvegicus (Norway rat)Potency37.68580.100020.879379.4328AID488772; AID588456
ATAD5 protein, partialHomo sapiens (human)Potency20.58780.004110.890331.5287AID493106
USP1 protein, partialHomo sapiens (human)Potency6.70160.031637.5844354.8130AID504865
DNA polymerase III, partialBacillus subtilisPotency33.58751.062114.152826.6795AID485295
regulator of G-protein signaling 4Homo sapiens (human)Potency37.68580.531815.435837.6858AID504845
ParkinHomo sapiens (human)Potency5.80480.819914.830644.6684AID720573
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency8.91250.035520.977089.1251AID504332
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency4.64510.016525.307841.3999AID602332
Bloom syndrome protein isoform 1Homo sapiens (human)Potency0.01580.540617.639296.1227AID2364; AID2528
atrial natriuretic peptide receptor 1 precursorHomo sapiens (human)Potency23.93410.134610.395030.1313AID1347049
runt-related transcription factor 1 isoform AML1bHomo sapiens (human)Potency11.14970.02007.985839.8107AID504374; AID504375
core-binding factor subunit beta isoform 2Homo sapiens (human)Potency11.14970.02007.985839.8107AID504374; AID504375
atrial natriuretic peptide receptor 2 precursorHomo sapiens (human)Potency8.26040.00669.809418.4927AID1347050
eyes absent homolog 2 isoform aHomo sapiens (human)Potency25.11891.199814.641950.1187AID488837
gemininHomo sapiens (human)Potency26.39170.004611.374133.4983AID463097; AID624296; AID624297
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency0.00450.005612.367736.1254AID624032
lamin isoform A-delta10Homo sapiens (human)Potency21.42150.891312.067628.1838AID1459; AID1487
neuropeptide S receptor isoform AHomo sapiens (human)Potency19.95260.015812.3113615.5000AID1461
Alpha-synucleinHomo sapiens (human)Potency29.09290.56239.398525.1189AID652106
Ataxin-2Homo sapiens (human)Potency3.54810.011912.222168.7989AID588378
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency37.93300.060110.745337.9330AID485368
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine/threonine-protein kinase D3Homo sapiens (human)IC50 (µMol)12.00000.00011.170110.0000AID164951
Protein kinase C gamma typeHomo sapiens (human)IC50 (µMol)12.00000.00011.035410.0000AID164951
Protein kinase C beta typeHomo sapiens (human)IC50 (µMol)12.00000.00010.554210.0000AID164951
Protein kinase C alpha typeHomo sapiens (human)IC50 (µMol)12.00000.00010.972010.0000AID164951
Platelet-activating factor receptorCavia porcellus (domestic guinea pig)IC50 (µMol)1.80000.00430.75777.8000AID165623
Protein kinase C eta typeHomo sapiens (human)IC50 (µMol)12.00000.00010.797110.0000AID164951
RAC-alpha serine/threonine-protein kinaseHomo sapiens (human)IC50 (µMol)3.50000.00020.738710.0000AID738313
Protein kinase C iota typeHomo sapiens (human)IC50 (µMol)12.00000.00012.037810.0000AID164951
Protein kinase C epsilon typeHomo sapiens (human)IC50 (µMol)12.00000.00010.802910.0000AID164951
Protein kinase C theta typeHomo sapiens (human)IC50 (µMol)12.00000.00010.989710.0000AID164951
Protein kinase C zeta typeHomo sapiens (human)IC50 (µMol)12.00000.00012.445310.0000AID164951
Protein kinase C delta typeHomo sapiens (human)IC50 (µMol)12.00000.00010.844810.0000AID164951
Serine/threonine-protein kinase D1Homo sapiens (human)IC50 (µMol)12.00000.00011.231910.0000AID164951
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (474)

Processvia Protein(s)Taxonomy
protein phosphorylationSerine/threonine-protein kinase D3Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwaySerine/threonine-protein kinase D3Homo sapiens (human)
sphingolipid biosynthetic processSerine/threonine-protein kinase D3Homo sapiens (human)
intracellular signal transductionSerine/threonine-protein kinase D3Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwaySerine/threonine-protein kinase D3Homo sapiens (human)
protein phosphorylationProtein kinase C gamma typeHomo sapiens (human)
chemical synaptic transmissionProtein kinase C gamma typeHomo sapiens (human)
learning or memoryProtein kinase C gamma typeHomo sapiens (human)
chemosensory behaviorProtein kinase C gamma typeHomo sapiens (human)
response to toxic substanceProtein kinase C gamma typeHomo sapiens (human)
phosphorylationProtein kinase C gamma typeHomo sapiens (human)
negative regulation of protein ubiquitinationProtein kinase C gamma typeHomo sapiens (human)
regulation of response to foodProtein kinase C gamma typeHomo sapiens (human)
positive regulation of mismatch repairProtein kinase C gamma typeHomo sapiens (human)
negative regulation of protein catabolic processProtein kinase C gamma typeHomo sapiens (human)
regulation of circadian rhythmProtein kinase C gamma typeHomo sapiens (human)
response to morphineProtein kinase C gamma typeHomo sapiens (human)
negative regulation of neuron apoptotic processProtein kinase C gamma typeHomo sapiens (human)
response to painProtein kinase C gamma typeHomo sapiens (human)
rhythmic processProtein kinase C gamma typeHomo sapiens (human)
regulation of phagocytosisProtein kinase C gamma typeHomo sapiens (human)
long-term synaptic potentiationProtein kinase C gamma typeHomo sapiens (human)
innervationProtein kinase C gamma typeHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionProtein kinase C gamma typeHomo sapiens (human)
negative regulation of proteasomal protein catabolic processProtein kinase C gamma typeHomo sapiens (human)
response to psychosocial stressProtein kinase C gamma typeHomo sapiens (human)
regulation of synaptic vesicle exocytosisProtein kinase C gamma typeHomo sapiens (human)
intracellular signal transductionProtein kinase C gamma typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C gamma typeHomo sapiens (human)
adaptive immune responseProtein kinase C beta typeHomo sapiens (human)
chromatin remodelingProtein kinase C beta typeHomo sapiens (human)
regulation of transcription by RNA polymerase IIProtein kinase C beta typeHomo sapiens (human)
protein phosphorylationProtein kinase C beta typeHomo sapiens (human)
calcium ion transportProtein kinase C beta typeHomo sapiens (human)
intracellular calcium ion homeostasisProtein kinase C beta typeHomo sapiens (human)
apoptotic processProtein kinase C beta typeHomo sapiens (human)
mitotic nuclear membrane disassemblyProtein kinase C beta typeHomo sapiens (human)
signal transductionProtein kinase C beta typeHomo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayProtein kinase C beta typeHomo sapiens (human)
response to xenobiotic stimulusProtein kinase C beta typeHomo sapiens (human)
response to glucoseProtein kinase C beta typeHomo sapiens (human)
regulation of glucose transmembrane transportProtein kinase C beta typeHomo sapiens (human)
negative regulation of glucose transmembrane transportProtein kinase C beta typeHomo sapiens (human)
regulation of dopamine secretionProtein kinase C beta typeHomo sapiens (human)
dibenzo-p-dioxin metabolic processProtein kinase C beta typeHomo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayProtein kinase C beta typeHomo sapiens (human)
positive regulation of insulin secretionProtein kinase C beta typeHomo sapiens (human)
response to vitamin DProtein kinase C beta typeHomo sapiens (human)
regulation of growthProtein kinase C beta typeHomo sapiens (human)
B cell activationProtein kinase C beta typeHomo sapiens (human)
positive regulation of odontogenesis of dentin-containing toothProtein kinase C beta typeHomo sapiens (human)
lipoprotein transportProtein kinase C beta typeHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionProtein kinase C beta typeHomo sapiens (human)
post-translational protein modificationProtein kinase C beta typeHomo sapiens (human)
response to ethanolProtein kinase C beta typeHomo sapiens (human)
positive regulation of angiogenesisProtein kinase C beta typeHomo sapiens (human)
positive regulation of DNA-templated transcriptionProtein kinase C beta typeHomo sapiens (human)
negative regulation of insulin receptor signaling pathwayProtein kinase C beta typeHomo sapiens (human)
B cell receptor signaling pathwayProtein kinase C beta typeHomo sapiens (human)
positive regulation of B cell receptor signaling pathwayProtein kinase C beta typeHomo sapiens (human)
cellular response to carbohydrate stimulusProtein kinase C beta typeHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionProtein kinase C beta typeHomo sapiens (human)
regulation of synaptic vesicle exocytosisProtein kinase C beta typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C beta typeHomo sapiens (human)
intracellular signal transductionProtein kinase C beta typeHomo sapiens (human)
angiogenesisProtein kinase C alpha typeHomo sapiens (human)
positive regulation of endothelial cell proliferationProtein kinase C alpha typeHomo sapiens (human)
desmosome assemblyProtein kinase C alpha typeHomo sapiens (human)
chromatin remodelingProtein kinase C alpha typeHomo sapiens (human)
protein phosphorylationProtein kinase C alpha typeHomo sapiens (human)
mitotic nuclear membrane disassemblyProtein kinase C alpha typeHomo sapiens (human)
cell adhesionProtein kinase C alpha typeHomo sapiens (human)
positive regulation of endothelial cell migrationProtein kinase C alpha typeHomo sapiens (human)
positive regulation of cardiac muscle hypertrophyProtein kinase C alpha typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C alpha typeHomo sapiens (human)
peptidyl-threonine phosphorylationProtein kinase C alpha typeHomo sapiens (human)
positive regulation of cell migrationProtein kinase C alpha typeHomo sapiens (human)
positive regulation of lipopolysaccharide-mediated signaling pathwayProtein kinase C alpha typeHomo sapiens (human)
negative regulation of glial cell apoptotic processProtein kinase C alpha typeHomo sapiens (human)
regulation of mRNA stabilityProtein kinase C alpha typeHomo sapiens (human)
positive regulation of blood vessel endothelial cell migrationProtein kinase C alpha typeHomo sapiens (human)
post-translational protein modificationProtein kinase C alpha typeHomo sapiens (human)
positive regulation of macrophage differentiationProtein kinase C alpha typeHomo sapiens (human)
positive regulation of angiogenesisProtein kinase C alpha typeHomo sapiens (human)
positive regulation of bone resorptionProtein kinase C alpha typeHomo sapiens (human)
positive regulation of cell adhesionProtein kinase C alpha typeHomo sapiens (human)
positive regulation of mitotic cell cycleProtein kinase C alpha typeHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeProtein kinase C alpha typeHomo sapiens (human)
response to interleukin-1Protein kinase C alpha typeHomo sapiens (human)
regulation of platelet aggregationProtein kinase C alpha typeHomo sapiens (human)
apoptotic signaling pathwayProtein kinase C alpha typeHomo sapiens (human)
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathwayProtein kinase C alpha typeHomo sapiens (human)
positive regulation of angiotensin-activated signaling pathwayProtein kinase C alpha typeHomo sapiens (human)
positive regulation of dense core granule biogenesisProtein kinase C alpha typeHomo sapiens (human)
intracellular signal transductionProtein kinase C alpha typeHomo sapiens (human)
positive regulation of insulin secretionProtein kinase C alpha typeHomo sapiens (human)
protein phosphorylationProtein kinase C eta typeHomo sapiens (human)
signal transductionProtein kinase C eta typeHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationProtein kinase C eta typeHomo sapiens (human)
cell differentiationProtein kinase C eta typeHomo sapiens (human)
negative regulation of glial cell apoptotic processProtein kinase C eta typeHomo sapiens (human)
positive regulation of keratinocyte differentiationProtein kinase C eta typeHomo sapiens (human)
positive regulation of B cell receptor signaling pathwayProtein kinase C eta typeHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityProtein kinase C eta typeHomo sapiens (human)
positive regulation of glial cell proliferationProtein kinase C eta typeHomo sapiens (human)
protein kinase C signalingProtein kinase C eta typeHomo sapiens (human)
positive regulation of protein localization to plasma membraneProtein kinase C eta typeHomo sapiens (human)
regulation of bicellular tight junction assemblyProtein kinase C eta typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C eta typeHomo sapiens (human)
intracellular signal transductionProtein kinase C eta typeHomo sapiens (human)
protein phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
activation-induced cell death of T cellsRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
intracellular signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
osteoblast differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
maternal placenta developmentRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of endothelial cell proliferationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell migration involved in sprouting angiogenesisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
sphingosine-1-phosphate receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
glycogen biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of glycogen biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
glucose metabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of translationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein import into nucleusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
nitric oxide biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
inflammatory responseRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to oxidative stressRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
epidermal growth factor receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
G protein-coupled receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
canonical NF-kappaB signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell population proliferationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
insulin receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
apoptotic mitochondrial changesRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to heatRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
gene expressionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of autophagyRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of endothelial cell migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of gene expressionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of gene expressionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of long-chain fatty acid import across plasma membraneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
fibroblast migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of fibroblast migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of sodium ion transportRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of glucose metabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of endopeptidase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of neuron projection developmentRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of macroautophagyRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein ubiquitinationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
peptidyl-serine phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
peptidyl-threonine phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
virus-mediated perturbation of host defense responseRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cytokine-mediated signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
mammalian oogenesis stageRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of cell growthRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of cell migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of cell migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
T cell costimulationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein ubiquitinationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of myelinationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
lipopolysaccharide-mediated signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
TOR signalingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of fatty acid beta-oxidationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of endodeoxyribonuclease activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to foodRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
peripheral nervous system myelin maintenanceRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to insulin stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to fluid shear stressRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to reactive oxygen speciesRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
interleukin-18-mediated signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to vascular endothelial growth factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to decreased oxygen levelsRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
non-canonical NF-kappaB signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
glucose homeostasisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of apoptotic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of apoptotic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
anoikisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of mRNA stabilityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of blood vessel endothelial cell migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of nitric oxide biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of fat cell differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of glycogen biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of Notch signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of proteolysisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of DNA-templated transcriptionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of glucose importRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of organ growthRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein autophosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of lipid biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
insulin-like growth factor receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
behavioral response to painRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of smooth muscle cell proliferationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of nitric-oxide synthase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
striated muscle cell differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein metabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
excitatory postsynaptic potentialRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to growth hormoneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
mammary gland epithelial cell differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
labyrinthine layer blood vessel developmentRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to UV-ARAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to growth factorRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to cadmium ionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to tumor necrosis factorRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to epidermal growth factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to prostaglandin E stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein serine/threonine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
establishment of protein localization to mitochondrionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
maintenance of protein location in mitochondrionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of release of cytochrome c from mitochondriaRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to granulocyte macrophage colony-stimulating factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
execution phase of apoptosisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of postsynapse organizationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of tRNA methylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to oxidised low-density lipoprotein particle stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein localization to lysosomeRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of cGAS/STING signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein localization to nucleusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to peptideRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of signal transduction by p53 class mediatorRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of cilium assemblyRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of leukocyte cell-cell adhesionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein localization to plasma membraneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of I-kappaB phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of TORC1 signalingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein localization to endoplasmic reticulumRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to nerve growth factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to insulin-like growth factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein localization to cell surfaceRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of type B pancreatic cell developmentRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of lymphocyte migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
intracellular signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein phosphorylationProtein kinase C iota typeHomo sapiens (human)
protein targeting to membraneProtein kinase C iota typeHomo sapiens (human)
cytoskeleton organizationProtein kinase C iota typeHomo sapiens (human)
actin filament organizationProtein kinase C iota typeHomo sapiens (human)
positive regulation of neuron projection developmentProtein kinase C iota typeHomo sapiens (human)
vesicle-mediated transportProtein kinase C iota typeHomo sapiens (human)
cell migrationProtein kinase C iota typeHomo sapiens (human)
cellular response to insulin stimulusProtein kinase C iota typeHomo sapiens (human)
negative regulation of glial cell apoptotic processProtein kinase C iota typeHomo sapiens (human)
establishment of apical/basal cell polarityProtein kinase C iota typeHomo sapiens (human)
eye photoreceptor cell developmentProtein kinase C iota typeHomo sapiens (human)
negative regulation of apoptotic processProtein kinase C iota typeHomo sapiens (human)
negative regulation of neuron apoptotic processProtein kinase C iota typeHomo sapiens (human)
establishment or maintenance of epithelial cell apical/basal polarityProtein kinase C iota typeHomo sapiens (human)
cell-cell junction organizationProtein kinase C iota typeHomo sapiens (human)
positive regulation of Notch signaling pathwayProtein kinase C iota typeHomo sapiens (human)
positive regulation of glucose importProtein kinase C iota typeHomo sapiens (human)
secretionProtein kinase C iota typeHomo sapiens (human)
Golgi vesicle buddingProtein kinase C iota typeHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityProtein kinase C iota typeHomo sapiens (human)
positive regulation of glial cell proliferationProtein kinase C iota typeHomo sapiens (human)
membrane organizationProtein kinase C iota typeHomo sapiens (human)
cellular response to chemical stressProtein kinase C iota typeHomo sapiens (human)
response to interleukin-1Protein kinase C iota typeHomo sapiens (human)
regulation of postsynaptic membrane neurotransmitter receptor levelsProtein kinase C iota typeHomo sapiens (human)
positive regulation of protein localization to plasma membraneProtein kinase C iota typeHomo sapiens (human)
positive regulation of endothelial cell apoptotic processProtein kinase C iota typeHomo sapiens (human)
intracellular signal transductionProtein kinase C iota typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C iota typeHomo sapiens (human)
MAPK cascadeProtein kinase C epsilon typeHomo sapiens (human)
macrophage activation involved in immune responseProtein kinase C epsilon typeHomo sapiens (human)
protein phosphorylationProtein kinase C epsilon typeHomo sapiens (human)
apoptotic processProtein kinase C epsilon typeHomo sapiens (human)
signal transductionProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of epithelial cell migrationProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of fibroblast migrationProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of cell-substrate adhesionProtein kinase C epsilon typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C epsilon typeHomo sapiens (human)
insulin secretionProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of actin filament polymerizationProtein kinase C epsilon typeHomo sapiens (human)
negative regulation of protein ubiquitinationProtein kinase C epsilon typeHomo sapiens (human)
cell-substrate adhesionProtein kinase C epsilon typeHomo sapiens (human)
lipopolysaccharide-mediated signaling pathwayProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of insulin secretionProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of cytokinesisProtein kinase C epsilon typeHomo sapiens (human)
locomotory exploration behaviorProtein kinase C epsilon typeHomo sapiens (human)
TRAM-dependent toll-like receptor 4 signaling pathwayProtein kinase C epsilon typeHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionProtein kinase C epsilon typeHomo sapiens (human)
response to morphineProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of MAPK cascadeProtein kinase C epsilon typeHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of lipid catabolic processProtein kinase C epsilon typeHomo sapiens (human)
regulation of release of sequestered calcium ion into cytosolProtein kinase C epsilon typeHomo sapiens (human)
cell divisionProtein kinase C epsilon typeHomo sapiens (human)
establishment of localization in cellProtein kinase C epsilon typeHomo sapiens (human)
synaptic transmission, GABAergicProtein kinase C epsilon typeHomo sapiens (human)
regulation of insulin secretion involved in cellular response to glucose stimulusProtein kinase C epsilon typeHomo sapiens (human)
mucus secretionProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of mucus secretionProtein kinase C epsilon typeHomo sapiens (human)
cellular response to ethanolProtein kinase C epsilon typeHomo sapiens (human)
cellular response to prostaglandin E stimulusProtein kinase C epsilon typeHomo sapiens (human)
cellular response to hypoxiaProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of wound healingProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of protein localization to plasma membraneProtein kinase C epsilon typeHomo sapiens (human)
negative regulation of sodium ion transmembrane transporter activityProtein kinase C epsilon typeHomo sapiens (human)
positive regulation of cellular glucuronidationProtein kinase C epsilon typeHomo sapiens (human)
intracellular signal transductionProtein kinase C epsilon typeHomo sapiens (human)
regulation of cell growthProtein kinase C theta typeHomo sapiens (human)
regulation of DNA-templated transcriptionProtein kinase C theta typeHomo sapiens (human)
protein phosphorylationProtein kinase C theta typeHomo sapiens (human)
membrane protein ectodomain proteolysisProtein kinase C theta typeHomo sapiens (human)
inflammatory responseProtein kinase C theta typeHomo sapiens (human)
axon guidanceProtein kinase C theta typeHomo sapiens (human)
positive regulation of telomere maintenance via telomeraseProtein kinase C theta typeHomo sapiens (human)
positive regulation of interleukin-17 productionProtein kinase C theta typeHomo sapiens (human)
positive regulation of interleukin-2 productionProtein kinase C theta typeHomo sapiens (human)
positive regulation of interleukin-4 productionProtein kinase C theta typeHomo sapiens (human)
intracellular signal transductionProtein kinase C theta typeHomo sapiens (human)
CD4-positive, alpha-beta T cell proliferationProtein kinase C theta typeHomo sapiens (human)
Fc-epsilon receptor signaling pathwayProtein kinase C theta typeHomo sapiens (human)
negative regulation of insulin receptor signaling pathwayProtein kinase C theta typeHomo sapiens (human)
positive regulation of T cell activationProtein kinase C theta typeHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityProtein kinase C theta typeHomo sapiens (human)
positive regulation of telomerase activityProtein kinase C theta typeHomo sapiens (human)
cell chemotaxisProtein kinase C theta typeHomo sapiens (human)
negative regulation of T cell apoptotic processProtein kinase C theta typeHomo sapiens (human)
regulation of platelet aggregationProtein kinase C theta typeHomo sapiens (human)
positive regulation of telomere cappingProtein kinase C theta typeHomo sapiens (human)
positive regulation of T-helper 17 type immune responseProtein kinase C theta typeHomo sapiens (human)
positive regulation of CD4-positive, alpha-beta T cell proliferationProtein kinase C theta typeHomo sapiens (human)
positive regulation of T-helper 2 cell activationProtein kinase C theta typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C theta typeHomo sapiens (human)
microtubule cytoskeleton organizationProtein kinase C zeta typeHomo sapiens (human)
positive regulation of cell-matrix adhesionProtein kinase C zeta typeHomo sapiens (human)
protein phosphorylationProtein kinase C zeta typeHomo sapiens (human)
inflammatory responseProtein kinase C zeta typeHomo sapiens (human)
signal transductionProtein kinase C zeta typeHomo sapiens (human)
cell surface receptor signaling pathwayProtein kinase C zeta typeHomo sapiens (human)
long-term memoryProtein kinase C zeta typeHomo sapiens (human)
positive regulation of cell population proliferationProtein kinase C zeta typeHomo sapiens (human)
cell migrationProtein kinase C zeta typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C zeta typeHomo sapiens (human)
establishment of cell polarityProtein kinase C zeta typeHomo sapiens (human)
negative regulation of protein-containing complex assemblyProtein kinase C zeta typeHomo sapiens (human)
positive regulation of interleukin-10 productionProtein kinase C zeta typeHomo sapiens (human)
positive regulation of interleukin-13 productionProtein kinase C zeta typeHomo sapiens (human)
positive regulation of interleukin-4 productionProtein kinase C zeta typeHomo sapiens (human)
positive regulation of interleukin-5 productionProtein kinase C zeta typeHomo sapiens (human)
cellular response to insulin stimulusProtein kinase C zeta typeHomo sapiens (human)
negative regulation of apoptotic processProtein kinase C zeta typeHomo sapiens (human)
establishment or maintenance of epithelial cell apical/basal polarityProtein kinase C zeta typeHomo sapiens (human)
positive regulation of T-helper 2 cell differentiationProtein kinase C zeta typeHomo sapiens (human)
negative regulation of insulin receptor signaling pathwayProtein kinase C zeta typeHomo sapiens (human)
positive regulation of insulin receptor signaling pathwayProtein kinase C zeta typeHomo sapiens (human)
vesicle transport along microtubuleProtein kinase C zeta typeHomo sapiens (human)
negative regulation of peptidyl-tyrosine phosphorylationProtein kinase C zeta typeHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityProtein kinase C zeta typeHomo sapiens (human)
positive regulation of protein transportProtein kinase C zeta typeHomo sapiens (human)
membrane depolarizationProtein kinase C zeta typeHomo sapiens (human)
membrane hyperpolarizationProtein kinase C zeta typeHomo sapiens (human)
long-term synaptic potentiationProtein kinase C zeta typeHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeProtein kinase C zeta typeHomo sapiens (human)
protein kinase C signalingProtein kinase C zeta typeHomo sapiens (human)
protein localization to plasma membraneProtein kinase C zeta typeHomo sapiens (human)
regulation of neurotransmitter receptor localization to postsynaptic specialization membraneProtein kinase C zeta typeHomo sapiens (human)
neuron projection extensionProtein kinase C zeta typeHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialProtein kinase C zeta typeHomo sapiens (human)
positive regulation of T-helper 2 cell cytokine productionProtein kinase C zeta typeHomo sapiens (human)
intracellular signal transductionProtein kinase C zeta typeHomo sapiens (human)
protein phosphorylationProtein kinase C delta typeHomo sapiens (human)
apoptotic processProtein kinase C delta typeHomo sapiens (human)
DNA damage responseProtein kinase C delta typeHomo sapiens (human)
signal transductionProtein kinase C delta typeHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stressProtein kinase C delta typeHomo sapiens (human)
regulation of signaling receptor activityProtein kinase C delta typeHomo sapiens (human)
immunoglobulin mediated immune responseProtein kinase C delta typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C delta typeHomo sapiens (human)
peptidyl-threonine phosphorylationProtein kinase C delta typeHomo sapiens (human)
termination of signal transductionProtein kinase C delta typeHomo sapiens (human)
negative regulation of actin filament polymerizationProtein kinase C delta typeHomo sapiens (human)
positive regulation of endodeoxyribonuclease activityProtein kinase C delta typeHomo sapiens (human)
negative regulation of protein bindingProtein kinase C delta typeHomo sapiens (human)
activation of protein kinase activityProtein kinase C delta typeHomo sapiens (human)
positive regulation of superoxide anion generationProtein kinase C delta typeHomo sapiens (human)
regulation of actin cytoskeleton organizationProtein kinase C delta typeHomo sapiens (human)
negative regulation of glial cell apoptotic processProtein kinase C delta typeHomo sapiens (human)
cellular response to UVProtein kinase C delta typeHomo sapiens (human)
positive regulation of protein dephosphorylationProtein kinase C delta typeHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisProtein kinase C delta typeHomo sapiens (human)
B cell proliferationProtein kinase C delta typeHomo sapiens (human)
neutrophil activationProtein kinase C delta typeHomo sapiens (human)
positive regulation of protein import into nucleusProtein kinase C delta typeHomo sapiens (human)
defense response to bacteriumProtein kinase C delta typeHomo sapiens (human)
negative regulation of MAP kinase activityProtein kinase C delta typeHomo sapiens (human)
regulation of mRNA stabilityProtein kinase C delta typeHomo sapiens (human)
post-translational protein modificationProtein kinase C delta typeHomo sapiens (human)
negative regulation of insulin receptor signaling pathwayProtein kinase C delta typeHomo sapiens (human)
negative regulation of inflammatory responseProtein kinase C delta typeHomo sapiens (human)
negative regulation of peptidyl-tyrosine phosphorylationProtein kinase C delta typeHomo sapiens (human)
protein stabilizationProtein kinase C delta typeHomo sapiens (human)
negative regulation of filopodium assemblyProtein kinase C delta typeHomo sapiens (human)
cell chemotaxisProtein kinase C delta typeHomo sapiens (human)
cellular response to hydrogen peroxideProtein kinase C delta typeHomo sapiens (human)
cellular response to hydroperoxideProtein kinase C delta typeHomo sapiens (human)
negative regulation of platelet aggregationProtein kinase C delta typeHomo sapiens (human)
cellular senescenceProtein kinase C delta typeHomo sapiens (human)
positive regulation of phospholipid scramblase activityProtein kinase C delta typeHomo sapiens (human)
cellular response to angiotensinProtein kinase C delta typeHomo sapiens (human)
regulation of ceramide biosynthetic processProtein kinase C delta typeHomo sapiens (human)
positive regulation of ceramide biosynthetic processProtein kinase C delta typeHomo sapiens (human)
positive regulation of glucosylceramide catabolic processProtein kinase C delta typeHomo sapiens (human)
positive regulation of sphingomyelin catabolic processProtein kinase C delta typeHomo sapiens (human)
positive regulation of apoptotic signaling pathwayProtein kinase C delta typeHomo sapiens (human)
intracellular signal transductionProtein kinase C delta typeHomo sapiens (human)
peptidyl-threonine phosphorylationSerine/threonine-protein kinase D1Homo sapiens (human)
angiogenesisSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of endothelial cell proliferationSerine/threonine-protein kinase D1Homo sapiens (human)
apoptotic processSerine/threonine-protein kinase D1Homo sapiens (human)
inflammatory responseSerine/threonine-protein kinase D1Homo sapiens (human)
Golgi organizationSerine/threonine-protein kinase D1Homo sapiens (human)
signal transductionSerine/threonine-protein kinase D1Homo sapiens (human)
integrin-mediated signaling pathwaySerine/threonine-protein kinase D1Homo sapiens (human)
nervous system developmentSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of autophagySerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of endothelial cell migrationSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of gene expressionSerine/threonine-protein kinase D1Homo sapiens (human)
regulation of keratinocyte proliferationSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of neuron projection developmentSerine/threonine-protein kinase D1Homo sapiens (human)
regulation of skeletal muscle contraction by modulation of calcium ion sensitivity of myofibrilSerine/threonine-protein kinase D1Homo sapiens (human)
peptidyl-serine phosphorylationSerine/threonine-protein kinase D1Homo sapiens (human)
peptidyl-threonine phosphorylationSerine/threonine-protein kinase D1Homo sapiens (human)
sphingolipid biosynthetic processSerine/threonine-protein kinase D1Homo sapiens (human)
cell differentiationSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationSerine/threonine-protein kinase D1Homo sapiens (human)
cellular response to amino acid starvationSerine/threonine-protein kinase D1Homo sapiens (human)
cellular response to oxidative stressSerine/threonine-protein kinase D1Homo sapiens (human)
intracellular signal transductionSerine/threonine-protein kinase D1Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of protein import into nucleusSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationSerine/threonine-protein kinase D1Homo sapiens (human)
innate immune responseSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of osteoblast differentiationSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of angiogenesisSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of cell sizeSerine/threonine-protein kinase D1Homo sapiens (human)
negative regulation of endocytosisSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IISerine/threonine-protein kinase D1Homo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of protein export from nucleusSerine/threonine-protein kinase D1Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwaySerine/threonine-protein kinase D1Homo sapiens (human)
Golgi vesicle transportSerine/threonine-protein kinase D1Homo sapiens (human)
defense response to Gram-negative bacteriumSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activitySerine/threonine-protein kinase D1Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of sarcomere organizationSerine/threonine-protein kinase D1Homo sapiens (human)
cellular response to hydroperoxideSerine/threonine-protein kinase D1Homo sapiens (human)
cellular response to norepinephrine stimulusSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of peptide hormone secretionSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of NLRP3 inflammasome complex assemblySerine/threonine-protein kinase D1Homo sapiens (human)
cellular response to angiotensinSerine/threonine-protein kinase D1Homo sapiens (human)
cellular response to phorbol 13-acetate 12-myristateSerine/threonine-protein kinase D1Homo sapiens (human)
cellular response to endothelinSerine/threonine-protein kinase D1Homo sapiens (human)
positive regulation of endothelial cell chemotaxisSerine/threonine-protein kinase D1Homo sapiens (human)
regulation of integrin-mediated signaling pathwaySerine/threonine-protein kinase D1Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwaySerine/threonine-protein kinase D1Homo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
cognitionAmyloid-beta precursor proteinHomo sapiens (human)
G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglial cell activationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
suckling behaviorAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activation involved in immune responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of translationAmyloid-beta precursor proteinHomo sapiens (human)
protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
intracellular copper ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
endocytosisAmyloid-beta precursor proteinHomo sapiens (human)
response to oxidative stressAmyloid-beta precursor proteinHomo sapiens (human)
cell adhesionAmyloid-beta precursor proteinHomo sapiens (human)
regulation of epidermal growth factor-activated receptor activityAmyloid-beta precursor proteinHomo sapiens (human)
Notch signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
axonogenesisAmyloid-beta precursor proteinHomo sapiens (human)
learning or memoryAmyloid-beta precursor proteinHomo sapiens (human)
learningAmyloid-beta precursor proteinHomo sapiens (human)
mating behaviorAmyloid-beta precursor proteinHomo sapiens (human)
locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
axo-dendritic transportAmyloid-beta precursor proteinHomo sapiens (human)
cholesterol metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of cell population proliferationAmyloid-beta precursor proteinHomo sapiens (human)
adult locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
visual learningAmyloid-beta precursor proteinHomo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglia developmentAmyloid-beta precursor proteinHomo sapiens (human)
axon midline choice point recognitionAmyloid-beta precursor proteinHomo sapiens (human)
neuron remodelingAmyloid-beta precursor proteinHomo sapiens (human)
dendrite developmentAmyloid-beta precursor proteinHomo sapiens (human)
regulation of Wnt signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
extracellular matrix organizationAmyloid-beta precursor proteinHomo sapiens (human)
forebrain developmentAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection developmentAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of chemokine productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-1 beta productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-6 productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of tumor necrosis factor productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of multicellular organism growthAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of neuron differentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of glycolytic processAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of JNK cascadeAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAmyloid-beta precursor proteinHomo sapiens (human)
collateral sprouting in absence of injuryAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of inflammatory responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of synapse structure or activityAmyloid-beta precursor proteinHomo sapiens (human)
synapse organizationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of calcium-mediated signalingAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular process controlling balanceAmyloid-beta precursor proteinHomo sapiens (human)
synaptic assembly at neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
neuron apoptotic processAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulum calcium ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
neuron cellular homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeAmyloid-beta precursor proteinHomo sapiens (human)
response to interleukin-1Amyloid-beta precursor proteinHomo sapiens (human)
modulation of excitatory postsynaptic potentialAmyloid-beta precursor proteinHomo sapiens (human)
NMDA selective glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of spontaneous synaptic transmissionAmyloid-beta precursor proteinHomo sapiens (human)
cytosolic mRNA polyadenylationAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionAmyloid-beta precursor proteinHomo sapiens (human)
cellular response to amyloid-betaAmyloid-beta precursor proteinHomo sapiens (human)
regulation of presynapse assemblyAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection maintenanceAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of T cell migrationAmyloid-beta precursor proteinHomo sapiens (human)
central nervous system developmentAmyloid-beta precursor proteinHomo sapiens (human)
calcium ion homeostasisAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIAlpha-synucleinHomo sapiens (human)
microglial cell activationAlpha-synucleinHomo sapiens (human)
positive regulation of receptor recyclingAlpha-synucleinHomo sapiens (human)
positive regulation of neurotransmitter secretionAlpha-synucleinHomo sapiens (human)
negative regulation of protein kinase activityAlpha-synucleinHomo sapiens (human)
fatty acid metabolic processAlpha-synucleinHomo sapiens (human)
neutral lipid metabolic processAlpha-synucleinHomo sapiens (human)
phospholipid metabolic processAlpha-synucleinHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
mitochondrial membrane organizationAlpha-synucleinHomo sapiens (human)
adult locomotory behaviorAlpha-synucleinHomo sapiens (human)
response to xenobiotic stimulusAlpha-synucleinHomo sapiens (human)
response to iron(II) ionAlpha-synucleinHomo sapiens (human)
regulation of phospholipase activityAlpha-synucleinHomo sapiens (human)
negative regulation of platelet-derived growth factor receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
regulation of glutamate secretionAlpha-synucleinHomo sapiens (human)
regulation of dopamine secretionAlpha-synucleinHomo sapiens (human)
synaptic vesicle exocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle primingAlpha-synucleinHomo sapiens (human)
regulation of transmembrane transporter activityAlpha-synucleinHomo sapiens (human)
negative regulation of microtubule polymerizationAlpha-synucleinHomo sapiens (human)
receptor internalizationAlpha-synucleinHomo sapiens (human)
protein destabilizationAlpha-synucleinHomo sapiens (human)
response to magnesium ionAlpha-synucleinHomo sapiens (human)
negative regulation of transporter activityAlpha-synucleinHomo sapiens (human)
response to lipopolysaccharideAlpha-synucleinHomo sapiens (human)
negative regulation of monooxygenase activityAlpha-synucleinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAlpha-synucleinHomo sapiens (human)
response to type II interferonAlpha-synucleinHomo sapiens (human)
cellular response to oxidative stressAlpha-synucleinHomo sapiens (human)
SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
positive regulation of SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
regulation of locomotionAlpha-synucleinHomo sapiens (human)
dopamine biosynthetic processAlpha-synucleinHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportAlpha-synucleinHomo sapiens (human)
regulation of macrophage activationAlpha-synucleinHomo sapiens (human)
positive regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of neuron apoptotic processAlpha-synucleinHomo sapiens (human)
positive regulation of endocytosisAlpha-synucleinHomo sapiens (human)
negative regulation of exocytosisAlpha-synucleinHomo sapiens (human)
positive regulation of exocytosisAlpha-synucleinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAlpha-synucleinHomo sapiens (human)
synaptic vesicle endocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle transportAlpha-synucleinHomo sapiens (human)
positive regulation of inflammatory responseAlpha-synucleinHomo sapiens (human)
regulation of acyl-CoA biosynthetic processAlpha-synucleinHomo sapiens (human)
protein tetramerizationAlpha-synucleinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolAlpha-synucleinHomo sapiens (human)
neuron apoptotic processAlpha-synucleinHomo sapiens (human)
dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of serotonin uptakeAlpha-synucleinHomo sapiens (human)
regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
negative regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
excitatory postsynaptic potentialAlpha-synucleinHomo sapiens (human)
long-term synaptic potentiationAlpha-synucleinHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processAlpha-synucleinHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
response to interleukin-1Alpha-synucleinHomo sapiens (human)
cellular response to copper ionAlpha-synucleinHomo sapiens (human)
cellular response to epinephrine stimulusAlpha-synucleinHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityAlpha-synucleinHomo sapiens (human)
supramolecular fiber organizationAlpha-synucleinHomo sapiens (human)
negative regulation of mitochondrial electron transport, NADH to ubiquinoneAlpha-synucleinHomo sapiens (human)
positive regulation of glutathione peroxidase activityAlpha-synucleinHomo sapiens (human)
positive regulation of hydrogen peroxide catabolic processAlpha-synucleinHomo sapiens (human)
regulation of synaptic vesicle recyclingAlpha-synucleinHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processAlpha-synucleinHomo sapiens (human)
positive regulation of protein localization to cell peripheryAlpha-synucleinHomo sapiens (human)
negative regulation of chaperone-mediated autophagyAlpha-synucleinHomo sapiens (human)
regulation of presynapse assemblyAlpha-synucleinHomo sapiens (human)
amyloid fibril formationAlpha-synucleinHomo sapiens (human)
synapse organizationAlpha-synucleinHomo sapiens (human)
chemical synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (78)

Processvia Protein(s)Taxonomy
diacylglycerol-dependent serine/threonine kinase activitySerine/threonine-protein kinase D3Homo sapiens (human)
protein bindingSerine/threonine-protein kinase D3Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase D3Homo sapiens (human)
kinase activitySerine/threonine-protein kinase D3Homo sapiens (human)
metal ion bindingSerine/threonine-protein kinase D3Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase D3Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase D3Homo sapiens (human)
protein kinase activityProtein kinase C gamma typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C gamma typeHomo sapiens (human)
calcium,diacylglycerol-dependent serine/threonine kinase activityProtein kinase C gamma typeHomo sapiens (human)
protein serine/threonine/tyrosine kinase activityProtein kinase C gamma typeHomo sapiens (human)
protein bindingProtein kinase C gamma typeHomo sapiens (human)
ATP bindingProtein kinase C gamma typeHomo sapiens (human)
zinc ion bindingProtein kinase C gamma typeHomo sapiens (human)
protein serine kinase activityProtein kinase C gamma typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C gamma typeHomo sapiens (human)
chromatin bindingProtein kinase C beta typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C beta typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C beta typeHomo sapiens (human)
protein kinase C bindingProtein kinase C beta typeHomo sapiens (human)
calcium channel regulator activityProtein kinase C beta typeHomo sapiens (human)
protein bindingProtein kinase C beta typeHomo sapiens (human)
ATP bindingProtein kinase C beta typeHomo sapiens (human)
zinc ion bindingProtein kinase C beta typeHomo sapiens (human)
nuclear receptor coactivator activityProtein kinase C beta typeHomo sapiens (human)
histone H3T6 kinase activityProtein kinase C beta typeHomo sapiens (human)
histone bindingProtein kinase C beta typeHomo sapiens (human)
nuclear androgen receptor bindingProtein kinase C beta typeHomo sapiens (human)
protein serine kinase activityProtein kinase C beta typeHomo sapiens (human)
protein kinase activityProtein kinase C alpha typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C alpha typeHomo sapiens (human)
calcium,diacylglycerol-dependent serine/threonine kinase activityProtein kinase C alpha typeHomo sapiens (human)
integrin bindingProtein kinase C alpha typeHomo sapiens (human)
protein bindingProtein kinase C alpha typeHomo sapiens (human)
ATP bindingProtein kinase C alpha typeHomo sapiens (human)
zinc ion bindingProtein kinase C alpha typeHomo sapiens (human)
enzyme bindingProtein kinase C alpha typeHomo sapiens (human)
histone H3T6 kinase activityProtein kinase C alpha typeHomo sapiens (human)
protein serine kinase activityProtein kinase C alpha typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C alpha typeHomo sapiens (human)
diacylglycerol bindingProtein kinase C alpha typeHomo sapiens (human)
protein kinase activityProtein kinase C eta typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C eta typeHomo sapiens (human)
diacylglycerol-dependent, calcium-independent serine/threonine kinase activityProtein kinase C eta typeHomo sapiens (human)
protein bindingProtein kinase C eta typeHomo sapiens (human)
ATP bindingProtein kinase C eta typeHomo sapiens (human)
enzyme bindingProtein kinase C eta typeHomo sapiens (human)
small GTPase bindingProtein kinase C eta typeHomo sapiens (human)
metal ion bindingProtein kinase C eta typeHomo sapiens (human)
protein serine kinase activityProtein kinase C eta typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C eta typeHomo sapiens (human)
protein kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein serine/threonine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein serine/threonine/tyrosine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
calmodulin bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
ATP bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
phosphatidylinositol-3,4,5-trisphosphate bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
enzyme bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein kinase bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
nitric-oxide synthase regulator activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein serine/threonine kinase inhibitor activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
identical protein bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein homodimerization activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
phosphatidylinositol-3,4-bisphosphate bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
14-3-3 protein bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
potassium channel activator activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein serine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein kinase activityProtein kinase C iota typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C iota typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C iota typeHomo sapiens (human)
protein bindingProtein kinase C iota typeHomo sapiens (human)
ATP bindingProtein kinase C iota typeHomo sapiens (human)
phospholipid bindingProtein kinase C iota typeHomo sapiens (human)
metal ion bindingProtein kinase C iota typeHomo sapiens (human)
protein serine kinase activityProtein kinase C iota typeHomo sapiens (human)
actin monomer bindingProtein kinase C epsilon typeHomo sapiens (human)
protein kinase activityProtein kinase C epsilon typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C epsilon typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C epsilon typeHomo sapiens (human)
diacylglycerol-dependent, calcium-independent serine/threonine kinase activityProtein kinase C epsilon typeHomo sapiens (human)
protein bindingProtein kinase C epsilon typeHomo sapiens (human)
ATP bindingProtein kinase C epsilon typeHomo sapiens (human)
enzyme activator activityProtein kinase C epsilon typeHomo sapiens (human)
enzyme bindingProtein kinase C epsilon typeHomo sapiens (human)
signaling receptor activator activityProtein kinase C epsilon typeHomo sapiens (human)
ethanol bindingProtein kinase C epsilon typeHomo sapiens (human)
metal ion bindingProtein kinase C epsilon typeHomo sapiens (human)
14-3-3 protein bindingProtein kinase C epsilon typeHomo sapiens (human)
protein serine kinase activityProtein kinase C epsilon typeHomo sapiens (human)
protein kinase activityProtein kinase C theta typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C theta typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C theta typeHomo sapiens (human)
protein bindingProtein kinase C theta typeHomo sapiens (human)
ATP bindingProtein kinase C theta typeHomo sapiens (human)
metal ion bindingProtein kinase C theta typeHomo sapiens (human)
protein serine kinase activityProtein kinase C theta typeHomo sapiens (human)
protein kinase activityProtein kinase C zeta typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C zeta typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C zeta typeHomo sapiens (human)
protein bindingProtein kinase C zeta typeHomo sapiens (human)
ATP bindingProtein kinase C zeta typeHomo sapiens (human)
potassium channel regulator activityProtein kinase C zeta typeHomo sapiens (human)
protein kinase bindingProtein kinase C zeta typeHomo sapiens (human)
phospholipase bindingProtein kinase C zeta typeHomo sapiens (human)
insulin receptor substrate bindingProtein kinase C zeta typeHomo sapiens (human)
protein-containing complex bindingProtein kinase C zeta typeHomo sapiens (human)
metal ion bindingProtein kinase C zeta typeHomo sapiens (human)
14-3-3 protein bindingProtein kinase C zeta typeHomo sapiens (human)
protein serine kinase activityProtein kinase C zeta typeHomo sapiens (human)
protein kinase activityProtein kinase C delta typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C delta typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C delta typeHomo sapiens (human)
diacylglycerol-dependent, calcium-independent serine/threonine kinase activityProtein kinase C delta typeHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityProtein kinase C delta typeHomo sapiens (human)
protein bindingProtein kinase C delta typeHomo sapiens (human)
ATP bindingProtein kinase C delta typeHomo sapiens (human)
enzyme activator activityProtein kinase C delta typeHomo sapiens (human)
enzyme bindingProtein kinase C delta typeHomo sapiens (human)
protein kinase bindingProtein kinase C delta typeHomo sapiens (human)
insulin receptor substrate bindingProtein kinase C delta typeHomo sapiens (human)
metal ion bindingProtein kinase C delta typeHomo sapiens (human)
protein serine kinase activityProtein kinase C delta typeHomo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase D1Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activitySerine/threonine-protein kinase D1Homo sapiens (human)
protein kinase C bindingSerine/threonine-protein kinase D1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase D1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase D1Homo sapiens (human)
kinase activitySerine/threonine-protein kinase D1Homo sapiens (human)
heat shock protein bindingSerine/threonine-protein kinase D1Homo sapiens (human)
identical protein bindingSerine/threonine-protein kinase D1Homo sapiens (human)
metal ion bindingSerine/threonine-protein kinase D1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase D1Homo sapiens (human)
phosphatidylinositol 3-kinase activator activitySerine/threonine-protein kinase D1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
serine-type endopeptidase inhibitor activityAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
heparin bindingAmyloid-beta precursor proteinHomo sapiens (human)
enzyme bindingAmyloid-beta precursor proteinHomo sapiens (human)
identical protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
transition metal ion bindingAmyloid-beta precursor proteinHomo sapiens (human)
receptor ligand activityAmyloid-beta precursor proteinHomo sapiens (human)
PTB domain bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein serine/threonine kinase bindingAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor activator activityAmyloid-beta precursor proteinHomo sapiens (human)
fatty acid bindingAlpha-synucleinHomo sapiens (human)
phospholipase D inhibitor activityAlpha-synucleinHomo sapiens (human)
SNARE bindingAlpha-synucleinHomo sapiens (human)
magnesium ion bindingAlpha-synucleinHomo sapiens (human)
transcription cis-regulatory region bindingAlpha-synucleinHomo sapiens (human)
actin bindingAlpha-synucleinHomo sapiens (human)
protein kinase inhibitor activityAlpha-synucleinHomo sapiens (human)
copper ion bindingAlpha-synucleinHomo sapiens (human)
calcium ion bindingAlpha-synucleinHomo sapiens (human)
protein bindingAlpha-synucleinHomo sapiens (human)
phospholipid bindingAlpha-synucleinHomo sapiens (human)
ferrous iron bindingAlpha-synucleinHomo sapiens (human)
zinc ion bindingAlpha-synucleinHomo sapiens (human)
lipid bindingAlpha-synucleinHomo sapiens (human)
oxidoreductase activityAlpha-synucleinHomo sapiens (human)
kinesin bindingAlpha-synucleinHomo sapiens (human)
Hsp70 protein bindingAlpha-synucleinHomo sapiens (human)
histone bindingAlpha-synucleinHomo sapiens (human)
identical protein bindingAlpha-synucleinHomo sapiens (human)
alpha-tubulin bindingAlpha-synucleinHomo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
tau protein bindingAlpha-synucleinHomo sapiens (human)
phosphoprotein bindingAlpha-synucleinHomo sapiens (human)
molecular adaptor activityAlpha-synucleinHomo sapiens (human)
dynein complex bindingAlpha-synucleinHomo sapiens (human)
cuprous ion bindingAlpha-synucleinHomo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (103)

Processvia Protein(s)Taxonomy
nucleoplasmSerine/threonine-protein kinase D3Homo sapiens (human)
cytosolSerine/threonine-protein kinase D3Homo sapiens (human)
plasma membraneSerine/threonine-protein kinase D3Homo sapiens (human)
cytosolSerine/threonine-protein kinase D3Homo sapiens (human)
nucleusProtein kinase C gamma typeHomo sapiens (human)
cytosolProtein kinase C gamma typeHomo sapiens (human)
plasma membraneProtein kinase C gamma typeHomo sapiens (human)
cell-cell junctionProtein kinase C gamma typeHomo sapiens (human)
postsynaptic densityProtein kinase C gamma typeHomo sapiens (human)
dendriteProtein kinase C gamma typeHomo sapiens (human)
calyx of HeldProtein kinase C gamma typeHomo sapiens (human)
perinuclear region of cytoplasmProtein kinase C gamma typeHomo sapiens (human)
synaptic membraneProtein kinase C gamma typeHomo sapiens (human)
presynaptic cytosolProtein kinase C gamma typeHomo sapiens (human)
postsynaptic cytosolProtein kinase C gamma typeHomo sapiens (human)
nucleusProtein kinase C beta typeHomo sapiens (human)
nucleoplasmProtein kinase C beta typeHomo sapiens (human)
cytoplasmProtein kinase C beta typeHomo sapiens (human)
centrosomeProtein kinase C beta typeHomo sapiens (human)
cytosolProtein kinase C beta typeHomo sapiens (human)
plasma membraneProtein kinase C beta typeHomo sapiens (human)
brush border membraneProtein kinase C beta typeHomo sapiens (human)
calyx of HeldProtein kinase C beta typeHomo sapiens (human)
extracellular exosomeProtein kinase C beta typeHomo sapiens (human)
presynaptic cytosolProtein kinase C beta typeHomo sapiens (human)
spectrinProtein kinase C beta typeHomo sapiens (human)
ciliary basal bodyProtein kinase C alpha typeHomo sapiens (human)
nucleoplasmProtein kinase C alpha typeHomo sapiens (human)
cytoplasmProtein kinase C alpha typeHomo sapiens (human)
mitochondrionProtein kinase C alpha typeHomo sapiens (human)
endoplasmic reticulumProtein kinase C alpha typeHomo sapiens (human)
cytosolProtein kinase C alpha typeHomo sapiens (human)
plasma membraneProtein kinase C alpha typeHomo sapiens (human)
mitochondrial membraneProtein kinase C alpha typeHomo sapiens (human)
perinuclear region of cytoplasmProtein kinase C alpha typeHomo sapiens (human)
extracellular exosomeProtein kinase C alpha typeHomo sapiens (human)
alphav-beta3 integrin-PKCalpha complexProtein kinase C alpha typeHomo sapiens (human)
cytoplasmProtein kinase C eta typeHomo sapiens (human)
cytosolProtein kinase C eta typeHomo sapiens (human)
plasma membraneProtein kinase C eta typeHomo sapiens (human)
cell-cell junctionProtein kinase C eta typeHomo sapiens (human)
extracellular exosomeProtein kinase C eta typeHomo sapiens (human)
cytoplasmRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
mitochondrial intermembrane spaceRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
membraneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
nucleusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
nucleoplasmRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cytoplasmRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
spindleRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cytosolRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
plasma membraneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell-cell junctionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell cortexRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
microtubule cytoskeletonRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
lamellipodiumRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
vesicleRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
ciliary basal bodyRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
postsynapseRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
glutamatergic synapseRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein-containing complexRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
Golgi membraneProtein kinase C iota typeHomo sapiens (human)
nucleusProtein kinase C iota typeHomo sapiens (human)
nucleoplasmProtein kinase C iota typeHomo sapiens (human)
endosomeProtein kinase C iota typeHomo sapiens (human)
cytosolProtein kinase C iota typeHomo sapiens (human)
plasma membraneProtein kinase C iota typeHomo sapiens (human)
brush borderProtein kinase C iota typeHomo sapiens (human)
bicellular tight junctionProtein kinase C iota typeHomo sapiens (human)
microtubule cytoskeletonProtein kinase C iota typeHomo sapiens (human)
apical plasma membraneProtein kinase C iota typeHomo sapiens (human)
cell leading edgeProtein kinase C iota typeHomo sapiens (human)
Schmidt-Lanterman incisureProtein kinase C iota typeHomo sapiens (human)
intercellular bridgeProtein kinase C iota typeHomo sapiens (human)
extracellular exosomeProtein kinase C iota typeHomo sapiens (human)
tight junctionProtein kinase C iota typeHomo sapiens (human)
Schaffer collateral - CA1 synapseProtein kinase C iota typeHomo sapiens (human)
glutamatergic synapseProtein kinase C iota typeHomo sapiens (human)
PAR polarity complexProtein kinase C iota typeHomo sapiens (human)
Golgi apparatusProtein kinase C epsilon typeHomo sapiens (human)
nucleusProtein kinase C epsilon typeHomo sapiens (human)
cytoplasmProtein kinase C epsilon typeHomo sapiens (human)
mitochondrionProtein kinase C epsilon typeHomo sapiens (human)
endoplasmic reticulumProtein kinase C epsilon typeHomo sapiens (human)
cytosolProtein kinase C epsilon typeHomo sapiens (human)
plasma membraneProtein kinase C epsilon typeHomo sapiens (human)
intracellular membrane-bounded organelleProtein kinase C epsilon typeHomo sapiens (human)
intermediate filament cytoskeletonProtein kinase C epsilon typeHomo sapiens (human)
synapseProtein kinase C epsilon typeHomo sapiens (human)
perinuclear region of cytoplasmProtein kinase C epsilon typeHomo sapiens (human)
cell peripheryProtein kinase C epsilon typeHomo sapiens (human)
immunological synapseProtein kinase C theta typeHomo sapiens (human)
cytosolProtein kinase C theta typeHomo sapiens (human)
plasma membraneProtein kinase C theta typeHomo sapiens (human)
aggresomeProtein kinase C theta typeHomo sapiens (human)
centriolar satelliteProtein kinase C theta typeHomo sapiens (human)
stress fiberProtein kinase C zeta typeHomo sapiens (human)
nuclear envelopeProtein kinase C zeta typeHomo sapiens (human)
cytoplasmProtein kinase C zeta typeHomo sapiens (human)
endosomeProtein kinase C zeta typeHomo sapiens (human)
microtubule organizing centerProtein kinase C zeta typeHomo sapiens (human)
cytosolProtein kinase C zeta typeHomo sapiens (human)
plasma membraneProtein kinase C zeta typeHomo sapiens (human)
cell-cell junctionProtein kinase C zeta typeHomo sapiens (human)
bicellular tight junctionProtein kinase C zeta typeHomo sapiens (human)
postsynaptic densityProtein kinase C zeta typeHomo sapiens (human)
membraneProtein kinase C zeta typeHomo sapiens (human)
apical plasma membraneProtein kinase C zeta typeHomo sapiens (human)
nuclear matrixProtein kinase C zeta typeHomo sapiens (human)
cell junctionProtein kinase C zeta typeHomo sapiens (human)
cell leading edgeProtein kinase C zeta typeHomo sapiens (human)
vesicleProtein kinase C zeta typeHomo sapiens (human)
myelin sheath abaxonal regionProtein kinase C zeta typeHomo sapiens (human)
axon hillockProtein kinase C zeta typeHomo sapiens (human)
apical cortexProtein kinase C zeta typeHomo sapiens (human)
perinuclear region of cytoplasmProtein kinase C zeta typeHomo sapiens (human)
extracellular exosomeProtein kinase C zeta typeHomo sapiens (human)
tight junctionProtein kinase C zeta typeHomo sapiens (human)
Schaffer collateral - CA1 synapseProtein kinase C zeta typeHomo sapiens (human)
glutamatergic synapseProtein kinase C zeta typeHomo sapiens (human)
PAR polarity complexProtein kinase C zeta typeHomo sapiens (human)
extracellular regionProtein kinase C delta typeHomo sapiens (human)
nucleusProtein kinase C delta typeHomo sapiens (human)
nucleoplasmProtein kinase C delta typeHomo sapiens (human)
cytoplasmProtein kinase C delta typeHomo sapiens (human)
mitochondrionProtein kinase C delta typeHomo sapiens (human)
endoplasmic reticulumProtein kinase C delta typeHomo sapiens (human)
cytosolProtein kinase C delta typeHomo sapiens (human)
plasma membraneProtein kinase C delta typeHomo sapiens (human)
cell-cell junctionProtein kinase C delta typeHomo sapiens (human)
nuclear matrixProtein kinase C delta typeHomo sapiens (human)
azurophil granule lumenProtein kinase C delta typeHomo sapiens (human)
endolysosomeProtein kinase C delta typeHomo sapiens (human)
perinuclear region of cytoplasmProtein kinase C delta typeHomo sapiens (human)
extracellular exosomeProtein kinase C delta typeHomo sapiens (human)
autophagosome membraneSerine/threonine-protein kinase D1Homo sapiens (human)
nucleusSerine/threonine-protein kinase D1Homo sapiens (human)
trans-Golgi networkSerine/threonine-protein kinase D1Homo sapiens (human)
cytosolSerine/threonine-protein kinase D1Homo sapiens (human)
plasma membraneSerine/threonine-protein kinase D1Homo sapiens (human)
cell-cell junctionSerine/threonine-protein kinase D1Homo sapiens (human)
cell cortexSerine/threonine-protein kinase D1Homo sapiens (human)
Z discSerine/threonine-protein kinase D1Homo sapiens (human)
perinuclear region of cytoplasmSerine/threonine-protein kinase D1Homo sapiens (human)
Golgi apparatusSerine/threonine-protein kinase D1Homo sapiens (human)
cytosolSerine/threonine-protein kinase D1Homo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
dendriteAmyloid-beta precursor proteinHomo sapiens (human)
extracellular regionAmyloid-beta precursor proteinHomo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
nuclear envelope lumenAmyloid-beta precursor proteinHomo sapiens (human)
cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
mitochondrial inner membraneAmyloid-beta precursor proteinHomo sapiens (human)
endosomeAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulum lumenAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
Golgi lumenAmyloid-beta precursor proteinHomo sapiens (human)
Golgi-associated vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cytosolAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
clathrin-coated pitAmyloid-beta precursor proteinHomo sapiens (human)
cell-cell junctionAmyloid-beta precursor proteinHomo sapiens (human)
synaptic vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
membraneAmyloid-beta precursor proteinHomo sapiens (human)
COPII-coated ER to Golgi transport vesicleAmyloid-beta precursor proteinHomo sapiens (human)
axonAmyloid-beta precursor proteinHomo sapiens (human)
growth coneAmyloid-beta precursor proteinHomo sapiens (human)
platelet alpha granule lumenAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
endosome lumenAmyloid-beta precursor proteinHomo sapiens (human)
trans-Golgi network membraneAmyloid-beta precursor proteinHomo sapiens (human)
ciliary rootletAmyloid-beta precursor proteinHomo sapiens (human)
dendritic spineAmyloid-beta precursor proteinHomo sapiens (human)
dendritic shaftAmyloid-beta precursor proteinHomo sapiens (human)
perikaryonAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
apical part of cellAmyloid-beta precursor proteinHomo sapiens (human)
synapseAmyloid-beta precursor proteinHomo sapiens (human)
perinuclear region of cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
presynaptic active zoneAmyloid-beta precursor proteinHomo sapiens (human)
spindle midzoneAmyloid-beta precursor proteinHomo sapiens (human)
recycling endosomeAmyloid-beta precursor proteinHomo sapiens (human)
extracellular exosomeAmyloid-beta precursor proteinHomo sapiens (human)
receptor complexAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
platelet alpha granule membraneAlpha-synucleinHomo sapiens (human)
extracellular regionAlpha-synucleinHomo sapiens (human)
extracellular spaceAlpha-synucleinHomo sapiens (human)
nucleusAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
mitochondrionAlpha-synucleinHomo sapiens (human)
lysosomeAlpha-synucleinHomo sapiens (human)
cytosolAlpha-synucleinHomo sapiens (human)
plasma membraneAlpha-synucleinHomo sapiens (human)
cell cortexAlpha-synucleinHomo sapiens (human)
actin cytoskeletonAlpha-synucleinHomo sapiens (human)
membraneAlpha-synucleinHomo sapiens (human)
inclusion bodyAlpha-synucleinHomo sapiens (human)
axonAlpha-synucleinHomo sapiens (human)
growth coneAlpha-synucleinHomo sapiens (human)
synaptic vesicle membraneAlpha-synucleinHomo sapiens (human)
perinuclear region of cytoplasmAlpha-synucleinHomo sapiens (human)
postsynapseAlpha-synucleinHomo sapiens (human)
supramolecular fiberAlpha-synucleinHomo sapiens (human)
protein-containing complexAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
axon terminusAlpha-synucleinHomo sapiens (human)
neuronal cell bodyAlpha-synucleinHomo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (204)

Assay IDTitleYearJournalArticle
AID1383404Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 24 hrs by propidium iodide staining based fluorescence microscopic analysis2018European journal of medicinal chemistry, Apr-10, Volume: 149Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.
AID1548142Selectivity index, ratio of IC50 for human THP1 cells to IC50 for antileishmanial activity against Leishmania donovani axenic amastigotes2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Tellurides Bearing Sulfonamides as Novel Inhibitors of Leishmanial Carbonic Anhydrase with Potent Antileishmanial Activity.
AID1384164Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 2.8%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID608354Cytotoxicity against human Jurkat cells assessed as live cells in neubauer chamber after 24 hrs by trypan blue assay2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
AID218121Effect on WHEI-3B cell growth expressed as percent number of colonies compared to contro at a concentration of 10 uM1993Journal of medicinal chemistry, Jan-22, Volume: 36, Issue:2
2'-(Trimethylammonio)ethyl 4-(hexadecyloxy)-3(S)-methoxybutanephosphonate: a novel potent antineoplastic agent.
AID1384147Induction of apoptosis in human PANC1 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 1.6 to 3.2%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID288968Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID232296Differential selectivity measured as the ratio of CEM-SS cell growth IC50 vs HIV plaque formation IC50.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
In vitro evaluation of phosphocholine and quaternary ammonium containing lipids as novel anti-HIV agents.
AID82512Standard thymidine incorporation assay (TdR) was carried out for 48 hr with an 8 hr pulse of [3H]- thymidine (TdR8) (n=16) and ID50 value was evaluated1993Journal of medicinal chemistry, Jul-09, Volume: 36, Issue:14
Synthesis of phosphocholine and quaternary amine ether lipids and evaluation of in vitro antineoplastic activity.
AID1384170Induction of apoptosis in human PK9 cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 3.8%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID81999Retained protein kinase C activity in the presence 2.5 uM compound1990Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.
AID288969Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID1383402Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by propidium iodide staining based fluorescence microscopic analysis2018European journal of medicinal chemistry, Apr-10, Volume: 149Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.
AID288970Antibacterial activity against vancomycin-resistant Enterococcus ATCC 51299 after 24 hrs2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID1126716Cytotoxicity against human BT474 cells assessed as cell viability at 20 uM after 6 days by MTS assay relative to untreated control2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID1484546Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes assessed as induction of cell death after 24 hrs by propidium iodide staining based flow cytometry2017European journal of medicinal chemistry, Jul-28, Volume: 135First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
AID1384155Induction of apoptosis in HPNE cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 0.7%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384184Induction of apoptosis in human MIAPaCa2 cells assessed as necrotic cells at 20 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 0.63%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID288955Antifungal activity against Candida albicans ATCC 102312007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID1384172Induction of apoptosis in human primary fibroblasts assessed as accumulation at sub-G0/G1 phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 4.8%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384177Induction of apoptosis in HPNE cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 6.6%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1126721Cytotoxicity against tumorspheres of human BT474 cells assessed as cell viability at 30 uM after 6 days by MTS assay relative to untreated control2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID7885Antiproliferative activity of compound was measured on human tumor cell line A431.1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
AID82002Retained protein kinase C activity in the presence of 5 uM compound1990Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.
AID1384194Induction of autophagy in human MIAPaCa2 cells assessed as increase in LC3-2 protein expression at 20 uM after 15 to 48 hrs by Western blot analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID288967Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID608453Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
AID1484545Antileishmanial activity against Leishmania infantum axenic amastigotes assessed as induction of cell death after 24 hrs by propidium iodide staining based flow cytometry2017European journal of medicinal chemistry, Jul-28, Volume: 135First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
AID1384139Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 2.3%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1069687Selectivity index, ratio of IC50 for human THP1 cells to IC50 for axenic amastigote stage of Leishmania infantum2014European journal of medicinal chemistry, Mar-03, Volume: 74Novel hybrid selenosulfonamides as potent antileishmanial agents.
AID81997Retained protein kinase C activity in the presence of 1.25 uM compound1990Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.
AID1384142Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase harboring pSFFV-Bcl-XL at 20 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 1.2%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384152Induction of apoptosis in human primary fibroblasts at 20 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 6.1%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1383403Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 axenic amastigotes infected in human THP1 cells after 24 hrs by propidium iodide staining based fluorescence microscopic analysis2018European journal of medicinal chemistry, Apr-10, Volume: 149Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.
AID530806Induction of apoptosis in wild-type Leishmania infantum promastigotes cells at 40 uM after 24 hrs by TUNEL assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.
AID1384175Induction of apoptosis in HPNE cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 0.6%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID165623PAF agonism was measured as the IC50 for aggregation of washed rabbit platelets after incubation for 30 min at 37 C.1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
AID530576Antileishmanial activity against GFP-tagged at NH2 terminus Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
AID738311Cytotoxicity against human MCF7 cells by flow cytometric analysis2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Synthesis, characterization and Akt phosphorylation inhibitory activity of cyclopentanecarboxylate-substituted alkylphosphocholines.
AID218117Compounds were evaluated for antineoplastic activity against WHEI-3B cells using clonogenic assays1993Journal of medicinal chemistry, Jan-22, Volume: 36, Issue:2
2'-(Trimethylammonio)ethyl 4-(hexadecyloxy)-3(S)-methoxybutanephosphonate: a novel potent antineoplastic agent.
AID1126713Cytotoxicity against human BT474 cells assessed as formation of spheroids with jagged rough edges at 10 to 20 uM after 6 days by phase contrast microscopy relative to untreated control2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID1384168Induction of apoptosis in human BxPC3 cells harboring pSFFV-Bcl-XL assessed as accumulation at sub-G0/G1 phase at 10 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 2%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID218120Effect on WHEI-3B cell growth expressed as percent number of colonies compared to contro at a concentration of 1.2 uM1993Journal of medicinal chemistry, Jan-22, Volume: 36, Issue:2
2'-(Trimethylammonio)ethyl 4-(hexadecyloxy)-3(S)-methoxybutanephosphonate: a novel potent antineoplastic agent.
AID1384148Induction of apoptosis in human PK9 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 2.2%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID530809Induction of apoptosis in Leishmania infantum promastigotes cells harboring with plasmid pX63 carrying Hrk gene at 40 uM after 24 hrs by TUNEL assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.
AID82507Standard thymidine incorporation assay (TdR) was carried out for 48 hr and involved a 24-h pulse of [3H]- thymidine (n=21) and ID50 value was evaluated1993Journal of medicinal chemistry, Jul-09, Volume: 36, Issue:14
Synthesis of phosphocholine and quaternary amine ether lipids and evaluation of in vitro antineoplastic activity.
AID1721834Ratio of IC50 for human THP1 cells to IC50 for axenic amastigote state of Leishmania infantum2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates.
AID1126717Cytotoxicity against tumorspheres of human BT474 cells assessed as disintegration of tumorspheres at 5 to 20 uM after 6 days by phase contrast microscopy relative to untreated control2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID1384141Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 3.4%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID218124Effect on WHEI-3B cell growth expressed as percent number of colonies compared to contro at a concentration of 5 uM1993Journal of medicinal chemistry, Jan-22, Volume: 36, Issue:2
2'-(Trimethylammonio)ethyl 4-(hexadecyloxy)-3(S)-methoxybutanephosphonate: a novel potent antineoplastic agent.
AID1384150Induction of apoptosis in human PK9 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 4%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384202Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 48 hrs in presence of autophagy inhibitor chloroquine by propidium iodide staining based flow cytometry2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID1384143Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase harboring pSFFV-Bcl-XL at 20 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 1.3%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID288962Toxicity assessed as haemolytic activity against human erythrocytes at 175 uM2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID82986Inhibitory dose against HL60 human leukemic cells after incubation for 48 h1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Synthesis and evaluation of neoplastic cell growth inhibition of 1-N-alkylamide analogues of glycero-3-phosphocholine.
AID96143Antiproliferative activity of compound was measured on human tumor cell line K-562.1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
AID1384144Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase harboring pSFFV-Bcl-XL at 20 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 1.3%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1069688Cytotoxicity against human THP1 cells after 24 hrs by propidium iodide staining-based flow cytometric analysis2014European journal of medicinal chemistry, Mar-03, Volume: 74Novel hybrid selenosulfonamides as potent antileishmanial agents.
AID608356Human intestinal absorption in human2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
AID608447Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes expressing GFP infected in human THP1 cells assessed as parasite infected cells at 3 uM after 48 hrs by flow cytometry (Rvb = 35%)2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
AID1384158Induction of apoptosis in human PANC1 cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 0.6 to 0.7%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384169Induction of apoptosis in human PK9 cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 2.2%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID530812Antimicrobial activity against Leishmania infantum promastigotes assessed as increase in DNA degradation after 24 hrs by flow cytometry2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.
AID530808Induction of apoptosis in Leishmania infantum promastigotes cells harboring with plasmid pX63 carrying Bcl-XL gene at 40 uM after 24 hrs by TUNEL assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.
AID288964Toxicity assessed as haemolytic activity against human erythrocytes at 44 uM2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID1384173Induction of apoptosis in human primary fibroblasts assessed as accumulation at sub-G0/G1 phase at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 6.1%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1069686Leishmanicidal activity against amastigote stage of Leishmania infantum expressing GFP infected in human THP1 cells after 48 hrs by flow cytometric analysis2014European journal of medicinal chemistry, Mar-03, Volume: 74Novel hybrid selenosulfonamides as potent antileishmanial agents.
AID1384151Induction of apoptosis in human primary fibroblasts at 20 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 4.8%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1548140Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as reduction in parasite growth measured after 24 hrs by propidium iodide staining based flow cytometric method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Tellurides Bearing Sulfonamides as Novel Inhibitors of Leishmanial Carbonic Anhydrase with Potent Antileishmanial Activity.
AID218123Effect on WHEI-3B cell growth expressed as percent number of colonies compared to contro at a concentration of 20 uM1993Journal of medicinal chemistry, Jan-22, Volume: 36, Issue:2
2'-(Trimethylammonio)ethyl 4-(hexadecyloxy)-3(S)-methoxybutanephosphonate: a novel potent antineoplastic agent.
AID1721832Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates.
AID1384159Induction of apoptosis in human PANC1 cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 0.2 to 2.9%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID608454Cytotoxicity against human THP1 cells assessed as live cells in neubauer chamber after 24 hrs by trypan blue assay2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
AID256022Lethal dose for Proliferation of human MDCK cells after 24 hr of treatment upon incubation for 6 h2005Journal of medicinal chemistry, Oct-20, Volume: 48, Issue:21
Glucosamine-glycerophospholipids that activate cell-matrix adhesion and migration.
AID81998Retained protein kinase C activity in the presence of 10 uM compound1990Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.
AID738312Cytotoxicity against human A549 cells by flow cytometric analysis2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Synthesis, characterization and Akt phosphorylation inhibitory activity of cyclopentanecarboxylate-substituted alkylphosphocholines.
AID608450Selectivity ratio, ratio of IC50 for human THP1 cells to IC50 for Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
AID89003Anti-HIV-1 activity against syncytial plaque formation1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity.
AID288965Toxicity assessed as haemolytic activity against human erythrocytes at 17.5 uM2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID164142Inhibition of Protein Kinase C purified from HL-60 cells1990Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.
AID282909Inhibition of Akt phosphorylation in MDA-MB-435 cells after 2 hrs2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue.
AID288963Toxicity assessed as haemolytic activity against human erythrocytes at 88 uM2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID608452Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
AID1384166Induction of apoptosis in human BxPC3 cells harboring pSFFV-Bcl-XL assessed as accumulation at sub-G0/G1 phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 1.5%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384185Induction of apoptosis in human MIAPaCa2 cells assessed as live cells at 20 uM after 48 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 86.79%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID530810Antimicrobial activity against Leishmania infantum promastigotes2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.
AID1721835Antileishmanial activity against axenic amastigote state of Leishmania infantum infected in human THP-1 cells at 3 uM incubated for 48 hrs2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates.
AID530577Antileishmanial activity against Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
AID1384182Induction of apoptosis in human MIAPaCa2 cells assessed as early apoptotic cells at 20 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 5.16%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384160Induction of apoptosis in human PANC1 cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 1.6 to 3.2%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384165Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 3.4%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID288961Toxicity assessed as haemolytic activity against human erythrocytes at 350 uM2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID1384154Induction of apoptosis in HPNE cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 0.6%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384146Induction of apoptosis in human PANC1 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 0.2 to 2.9%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384201Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 48 hrs in presence of autophagy inhibitor 3-MA by propidium iodide staining based flow cytometry2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384163Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 1.8%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID89134Concentration of compound required to 50% growth inhibition of HIV-1 in CEM-SS cells1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity.
AID1384167Induction of apoptosis in human BxPC3 cells harboring pSFFV-Bcl-XL assessed as accumulation at sub-G0/G1 phase at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 1.9%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID46608In vitro inhibition of CEM-SS cell growth by 50 %1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
In vitro evaluation of phosphocholine and quaternary ammonium containing lipids as novel anti-HIV agents.
AID81301Antiproliferative activity of compound was measured on human tumor cell line HL-60.1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
AID1384183Induction of apoptosis in human MIAPaCa2 cells assessed as late apoptotic cells at 20 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 7.4%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID608355Permeability across human Caco2 cells2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
AID1384190Induction of apoptosis in human BxPC3 cells assessed as increase in cleaved PARP protein expression at 20 uM after 15 to 48 hrs by Western blot analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID196737Maximal non-erythrolytic concentration(MNEC) was measured in erythrocytes from rat citreated blood1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
AID1384181Induction of apoptosis in human MIAPaCa2 cells assessed as live cells at 20 uM after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 86.79%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID530578Antileishmanial activity against GFP-tagged at COOH terminus Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
AID530807Induction of apoptosis in Leishmania infantum promastigotes cells harboring pX63 expression vector at 40 uM after 24 hrs by TUNEL assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.
AID288966Toxicity assessed as haemolytic activity against human erythrocytes at 3.5 uM2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID1384136Growth inhibition of human PANC1 cells after 72 hrs by XTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID82501Inhibition of neoplastic cell proliferation in the HL-60 human promyelocytic leukemia cells1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis of quaternary amine ether lipids and evaluation of neoplastic cell growth inhibitory properties.
AID164951Inhibition of Protein Kinase C (PKC) isolated from HL-60 human promyelocytic leukemia cells1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis of quaternary amine ether lipids and evaluation of neoplastic cell growth inhibitory properties.
AID1548143Antileishmanial activity against Leishmania donovani amastigotes infected in human THP1 cells assessed as reduction in parasite infection at 3 uM measured after 48 hrs by GFP-reporter based flow cytometric method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Tellurides Bearing Sulfonamides as Novel Inhibitors of Leishmanial Carbonic Anhydrase with Potent Antileishmanial Activity.
AID530811Antimicrobial activity against Leishmania infantum promastigotes assessed as increase in hypodiploid cell formation after 24 hrs by flow cytometry2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.
AID608451Selectivity ratio, ratio of IC50 for human Jurkat cells to IC50 for Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
AID1384199Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 48 hrs in presence of autophagy inhibitor bafilomycin A1 by propidium iodide staining based flow cytometry2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384149Induction of apoptosis in human PK9 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 3.8%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID282910Cytotoxicity against human MDA-MB-435 cells after 3 days in serum free conditions by MTT assay2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue.
AID1484547Cytotoxicity against human THP1 cells assessed as induction of cell death after 24 hrs by propidium iodide staining based flow cytometry2017European journal of medicinal chemistry, Jul-28, Volume: 135First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
AID82001Retained protein kinase C activity in the presence of 40 uM compound1990Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.
AID82000Retained protein kinase C activity in the presence of 20 uM compound1990Journal of medicinal chemistry, Mar, Volume: 33, Issue:3
Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.
AID1384140Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 2.8%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID89000In vitro inhibition of HIV-1 plaque formation1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
In vitro evaluation of phosphocholine and quaternary ammonium containing lipids as novel anti-HIV agents.
AID1384145Induction of apoptosis in human PANC1 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 0.6 to 0.7%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384193Induction of apoptosis in human BxPC3 cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 24 to 48 hrs in presence of caspase inhibitor zVAD-fmk by propidium iodide staining based flow cytometry2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID218122Effect on WHEI-3B cell growth expressed as percent number of colonies compared to contro at a concentration of 2.5 uM1993Journal of medicinal chemistry, Jan-22, Volume: 36, Issue:2
2'-(Trimethylammonio)ethyl 4-(hexadecyloxy)-3(S)-methoxybutanephosphonate: a novel potent antineoplastic agent.
AID738310Cytotoxicity against human KATO III cells by flow cytometric analysis2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Synthesis, characterization and Akt phosphorylation inhibitory activity of cyclopentanecarboxylate-substituted alkylphosphocholines.
AID218119Effect on WHEI-3B cell growth expressed as percent number of colonies compared to contro at a concentration of 0.6 uM1993Journal of medicinal chemistry, Jan-22, Volume: 36, Issue:2
2'-(Trimethylammonio)ethyl 4-(hexadecyloxy)-3(S)-methoxybutanephosphonate: a novel potent antineoplastic agent.
AID738313Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Synthesis, characterization and Akt phosphorylation inhibitory activity of cyclopentanecarboxylate-substituted alkylphosphocholines.
AID82649Trypan blue exclusion assay (TB) was carried out for 48 hr and the in vitro ID50 value was evaluated in the HL-60 leukemic cell system (n=33)1993Journal of medicinal chemistry, Jul-09, Volume: 36, Issue:14
Synthesis of phosphocholine and quaternary amine ether lipids and evaluation of in vitro antineoplastic activity.
AID1384174Induction of apoptosis in human primary fibroblasts assessed as accumulation at sub-G0/G1 phase at 10 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 6.7%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384189Induction of apoptosis in human MIAPaCa2 cells assessed as increase in cleaved PARP protein expression at 20 uM after 15 to 48 hrs by Western blot analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384171Induction of apoptosis in human PK9 cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 4%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384186Induction of apoptosis in human MIAPaCa2 cells assessed as early apoptotic cells at 20 uM after 48 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 5.16%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384195Induction of autophagy in human BxPC3 cells assessed as increase in LC3-2 protein expression at 20 uM after 15 to 48 hrs by Western blot analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID19827Partition coefficient (logP)1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
AID1384176Induction of apoptosis in HPNE cells assessed as accumulation at sub-G0/G1 phase at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 0.7%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384153Induction of apoptosis in human primary fibroblasts at 20 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 6.7%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1384135Growth inhibition of human BxPC3 cells after 72 hrs by XTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID288954Antifungal activity against Cryptococcus neoformans ATCC 901122007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
AID1126720Cytotoxicity against tumorspheres of human BT474 cells assessed as inhibition of cell viability at 20 uM after 6 days by MTS assay relative to untreated control2014European journal of medicinal chemistry, May-06, Volume: 78Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
AID1384188Induction of apoptosis in human MIAPaCa2 cells assessed as necrotic cells at 20 uM after 48 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 0.63%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1548141Cytotoxicity against human THP1 cells assessed as reduction in cell viability measured after 24 hrs by propidium iodide staining based flow cytometry2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Tellurides Bearing Sulfonamides as Novel Inhibitors of Leishmanial Carbonic Anhydrase with Potent Antileishmanial Activity.
AID81463Cytotoxicity measured in HL-60 leukemic cells after a 24 hr incubation period.1995Journal of medicinal chemistry, Mar-31, Volume: 38, Issue:7
Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
AID1384187Induction of apoptosis in human MIAPaCa2 cells assessed as late apoptotic cells at 20 uM after 48 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 7.4%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1721833Cytotoxicity against human THP-1 cells assessed as reduction in cell viability incubated for 24 hrs2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates.
AID1069689Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis2014European journal of medicinal chemistry, Mar-03, Volume: 74Novel hybrid selenosulfonamides as potent antileishmanial agents.
AID1384156Induction of apoptosis in HPNE cells assessed as accumulation at sub-G0/G1 phase at 20 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 6.6%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID486214Toxicity in rat RBL2H3 cells2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Computational screening for membrane-directed inhibitors of mast cell activation.
AID150374Inhibitor activity against P388 (murine leukemia )cell line with varying concentration of the drug for 72 hrs1996Journal of medicinal chemistry, Aug-16, Volume: 39, Issue:17
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
AID82836Compound was tested for the inhibition of human HL60 Leukemia1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID98192Inhibitor activity against L1210 (murine leukemia )cell line with varying concentration of the drug for 72 hrs1996Journal of medicinal chemistry, Aug-16, Volume: 39, Issue:17
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
AID103293Inhibitor activity against Lewis lung (murine lung carcinoma)cell line with varying concentration of the drug for 72 hrs1996Journal of medicinal chemistry, Aug-16, Volume: 39, Issue:17
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
AID97118Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent increase in life span at 5 mg/kg (treatment of 1-5qd schedule) dosage1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID1503182Leishmanicidal activity against Leishmania infantum amastigotes after 24 hrs by propidium iodide staining based flow cytometry
AID96850Antitumor activity was determined against the ip implanted L1210 leukemia in mice by range in survival days at 5 mg/kg (treatment of 1-5qd schedule) dosage; Range is 8-91986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID1503181Leishmanicidal activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by propidium iodide staining based flow cytometry
AID86096Inhibitor activity against HT-29 (Human colon carcinoma)cell line with varying concentration of the drug for 72 hrs1996Journal of medicinal chemistry, Aug-16, Volume: 39, Issue:17
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
AID150375Inhibitor activity against P388/Adr (murine leukemia )cell line with varying concentration of the drug for 72 hrs1996Journal of medicinal chemistry, Aug-16, Volume: 39, Issue:17
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
AID103880Inhibitor activity against MCF-7/Adr (Human colon carcinoma)cell line with varying concentration of the drug for 72 hrs1996Journal of medicinal chemistry, Aug-16, Volume: 39, Issue:17
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
AID31435Compound was tested for the inhibition of AMML (acute myelomonocytic leukemia)1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID205131Compound was tested for the inhibition of small cell lung cancer1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID97294Antitumor activity was determined against the ip implanted L1210 leukemia in mice by 45-day survivors in mice at 5 mg/kg (treatment of 1-5qd schedule) dosage1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID1503183Cytotoxicity against human THP1 cells after 24 hrs by propidium iodide staining based flow cytometry
AID98957Antitumor activity against the ip implanted L1210 leukemia in mice expressed as optimal dose (1-5qd treatment schedule) required to produce greatest increase in life span was determined1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID147430Compound was tested for the inhibition of non- small cell lung cancer1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID486213Inhibition of rat RBL2H3 cell granulation assessed as reduction of beta hexasaminidase release2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Computational screening for membrane-directed inhibitors of mast cell activation.
AID103879Inhibitor activity against MCF-7(Human breast carcinoma)cell line with varying concentration of the drug for 72 hrs1996Journal of medicinal chemistry, Aug-16, Volume: 39, Issue:17
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
AID486215Inhibition of rat RBL2H3 cell granulation assessed as reduction of beta hexasaminidase release at 25 uM2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Computational screening for membrane-directed inhibitors of mast cell activation.
AID98193Inhibitor activity against L1210/vmdr (transfected with a plasmid containing mdr1) cell line with varying concentration of the drug for 72 hrs1996Journal of medicinal chemistry, Aug-16, Volume: 39, Issue:17
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
AID75536Compound was tested for the inhibition of glioblastoma1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID8477Inhibitor activity against A549 (Human lung carcinoma)cell line with varying concentration of the drug for 72 hrs1996Journal of medicinal chemistry, Aug-16, Volume: 39, Issue:17
Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
AID97760Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent median survival rate (treated/control) at 5 mg/kg (treatment of 1-5qd schedule) dosage; 9.0/8.01986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID45763Compound was tested for the inhibition of CML/BC(chronic myeloid leukemia, blast crisis)1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
AID1503185Selectivity index, ratio of LC50 for cytotoxicity against human THP1 cells to LC50 for leishmanicidal activity against Leishmania infantum amastigotes
AID1503184Selectivity index, ratio of LC50 for cytotoxicity against human THP1 cells to LC50 for leishmanicidal activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (444)

TimeframeStudies, This Drug (%)All Drugs %
pre-199057 (12.84)18.7374
1990's158 (35.59)18.2507
2000's116 (26.13)29.6817
2010's96 (21.62)24.3611
2020's17 (3.83)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.94 (24.57)
Research Supply Index6.14 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (1.54%)5.53%
Trials0 (0.00%)5.53%
Reviews23 (5.07%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other424 (93.39%)84.16%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]